Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, Large B-Cell, Diffuse | 132 | 2023 | 1664 | 11.820 |
Why?
|
Lymphoma, B-Cell | 93 | 2023 | 895 | 9.000 |
Why?
|
Immunophenotyping | 202 | 2023 | 1681 | 7.440 |
Why?
|
Hodgkin Disease | 80 | 2023 | 1429 | 6.220 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 46 | 2023 | 387 | 6.180 |
Why?
|
Translocation, Genetic | 93 | 2022 | 1245 | 5.980 |
Why?
|
Lymphoma, Mantle-Cell | 58 | 2023 | 713 | 5.760 |
Why?
|
Gene Rearrangement | 60 | 2023 | 783 | 5.110 |
Why?
|
Proto-Oncogene Proteins c-myc | 38 | 2023 | 810 | 5.060 |
Why?
|
In Situ Hybridization, Fluorescence | 100 | 2023 | 2232 | 4.910 |
Why?
|
Immunohistochemistry | 222 | 2023 | 7548 | 4.860 |
Why?
|
Lymphoma, T-Cell | 38 | 2022 | 361 | 4.820 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 57 | 2023 | 1493 | 4.240 |
Why?
|
Lymphoma, Follicular | 40 | 2021 | 587 | 4.160 |
Why?
|
Biomarkers, Tumor | 153 | 2023 | 10331 | 4.120 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 76 | 2023 | 2390 | 4.030 |
Why?
|
Epstein-Barr Virus Infections | 22 | 2021 | 489 | 3.940 |
Why?
|
Lymphoma, Non-Hodgkin | 74 | 2020 | 1039 | 3.840 |
Why?
|
Bone Marrow | 99 | 2023 | 2358 | 3.780 |
Why?
|
Chromosome Aberrations | 68 | 2023 | 1960 | 3.620 |
Why?
|
Myelodysplastic Syndromes | 67 | 2023 | 2979 | 3.580 |
Why?
|
Middle Aged | 607 | 2023 | 86204 | 3.480 |
Why?
|
Aged | 530 | 2023 | 70117 | 3.370 |
Why?
|
Lymphoma, T-Cell, Peripheral | 19 | 2022 | 181 | 3.300 |
Why?
|
Humans | 1041 | 2024 | 261506 | 3.300 |
Why?
|
Adult | 547 | 2023 | 77950 | 3.280 |
Why?
|
Leukemia, Myeloid, Acute | 87 | 2024 | 6915 | 3.250 |
Why?
|
Lymphoma | 47 | 2023 | 1467 | 3.250 |
Why?
|
Lymphoproliferative Disorders | 16 | 2022 | 366 | 3.180 |
Why?
|
Flow Cytometry | 92 | 2022 | 3033 | 3.180 |
Why?
|
Male | 661 | 2023 | 123000 | 3.070 |
Why?
|
Mutation | 140 | 2023 | 15179 | 3.010 |
Why?
|
Castleman Disease | 9 | 2020 | 69 | 2.940 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 23 | 2021 | 301 | 2.820 |
Why?
|
Breast Implants | 14 | 2023 | 391 | 2.730 |
Why?
|
Protein-Tyrosine Kinases | 47 | 2023 | 1756 | 2.730 |
Why?
|
Genes, myc | 18 | 2021 | 358 | 2.720 |
Why?
|
Female | 647 | 2023 | 141928 | 2.720 |
Why?
|
Aged, 80 and over | 278 | 2023 | 29902 | 2.650 |
Why?
|
Herpesvirus 4, Human | 46 | 2023 | 966 | 2.620 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 36 | 2024 | 2527 | 2.610 |
Why?
|
Neoplasms, Second Primary | 35 | 2021 | 1350 | 2.600 |
Why?
|
Myeloproliferative Disorders | 28 | 2023 | 767 | 2.500 |
Why?
|
Germinal Center | 18 | 2021 | 161 | 2.490 |
Why?
|
Neoplasm Proteins | 41 | 2022 | 3230 | 2.470 |
Why?
|
Tumor Suppressor Protein p53 | 55 | 2022 | 3552 | 2.440 |
Why?
|
Lymph Nodes | 66 | 2020 | 2967 | 2.440 |
Why?
|
High-Throughput Nucleotide Sequencing | 38 | 2023 | 2291 | 2.260 |
Why?
|
Karyotyping | 51 | 2021 | 1022 | 2.260 |
Why?
|
Chromosomes, Human, Pair 14 | 30 | 2020 | 272 | 2.250 |
Why?
|
Hematologic Neoplasms | 24 | 2023 | 1870 | 2.220 |
Why?
|
Burkitt Lymphoma | 15 | 2021 | 335 | 2.190 |
Why?
|
Prognosis | 178 | 2023 | 21713 | 2.150 |
Why?
|
Proto-Oncogene Proteins | 47 | 2023 | 2488 | 2.130 |
Why?
|
Chromosomes, Human, Pair 8 | 24 | 2019 | 317 | 2.110 |
Why?
|
Lymphocytes | 19 | 2022 | 1234 | 2.070 |
Why?
|
Cyclin D1 | 27 | 2023 | 576 | 2.040 |
Why?
|
Diagnosis, Differential | 82 | 2022 | 4744 | 1.970 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 116 | 2022 | 15862 | 1.900 |
Why?
|
Splenic Neoplasms | 12 | 2017 | 119 | 1.890 |
Why?
|
Fusion Proteins, bcr-abl | 17 | 2023 | 1094 | 1.890 |
Why?
|
Plasmacytoma | 11 | 2021 | 111 | 1.840 |
Why?
|
Waldenstrom Macroglobulinemia | 16 | 2019 | 273 | 1.800 |
Why?
|
Polymerase Chain Reaction | 71 | 2017 | 3203 | 1.770 |
Why?
|
Young Adult | 137 | 2021 | 21445 | 1.720 |
Why?
|
Hyperalgesia | 9 | 2020 | 238 | 1.720 |
Why?
|
Sarcoma, Myeloid | 8 | 2016 | 95 | 1.690 |
Why?
|
Receptor Protein-Tyrosine Kinases | 39 | 2023 | 661 | 1.680 |
Why?
|
Chromosomes, Human, Pair 18 | 18 | 2012 | 181 | 1.660 |
Why?
|
DNA Mutational Analysis | 43 | 2023 | 2283 | 1.650 |
Why?
|
B-Lymphocytes | 38 | 2021 | 1294 | 1.650 |
Why?
|
Rituximab | 52 | 2022 | 1528 | 1.630 |
Why?
|
Chromosomes, Human, Pair 11 | 18 | 2020 | 402 | 1.630 |
Why?
|
Antigens, CD | 52 | 2019 | 1385 | 1.610 |
Why?
|
Leukemia, Myeloid | 21 | 2021 | 941 | 1.600 |
Why?
|
Skin Neoplasms | 45 | 2022 | 4654 | 1.570 |
Why?
|
Adolescent | 172 | 2021 | 31252 | 1.550 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 18 | 2023 | 125 | 1.540 |
Why?
|
Blast Crisis | 20 | 2021 | 557 | 1.530 |
Why?
|
Ki-1 Antigen | 22 | 2023 | 182 | 1.530 |
Why?
|
Trisomy | 15 | 2016 | 231 | 1.520 |
Why?
|
Transcranial Direct Current Stimulation | 9 | 2021 | 20 | 1.470 |
Why?
|
Breast Implantation | 10 | 2023 | 228 | 1.460 |
Why?
|
Janus Kinase 2 | 15 | 2023 | 679 | 1.460 |
Why?
|
Oncogene Proteins, Fusion | 26 | 2022 | 755 | 1.440 |
Why?
|
Stem Cell Transplantation | 22 | 2022 | 1360 | 1.410 |
Why?
|
Multiple Myeloma | 22 | 2023 | 2138 | 1.400 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 14 | 2022 | 426 | 1.400 |
Why?
|
Cell Transformation, Neoplastic | 25 | 2021 | 2359 | 1.400 |
Why?
|
Bone Marrow Neoplasms | 9 | 2019 | 132 | 1.380 |
Why?
|
CD5 Antigens | 12 | 2017 | 112 | 1.370 |
Why?
|
Leukemia, Prolymphocytic | 7 | 2023 | 51 | 1.350 |
Why?
|
Nuclear Proteins | 33 | 2022 | 3343 | 1.330 |
Why?
|
Genes, bcl-2 | 10 | 2020 | 166 | 1.320 |
Why?
|
Gene Expression Regulation, Neoplastic | 49 | 2020 | 8873 | 1.310 |
Why?
|
Leukemia, Prolymphocytic, T-Cell | 7 | 2023 | 43 | 1.310 |
Why?
|
Herpesviridae Infections | 5 | 2019 | 175 | 1.300 |
Why?
|
Antigens, CD20 | 18 | 2017 | 206 | 1.300 |
Why?
|
fms-Like Tyrosine Kinase 3 | 22 | 2021 | 801 | 1.280 |
Why?
|
Bone Marrow Cells | 32 | 2018 | 943 | 1.270 |
Why?
|
Histiocytosis, Langerhans-Cell | 8 | 2021 | 261 | 1.270 |
Why?
|
Plasma Cells | 13 | 2021 | 192 | 1.250 |
Why?
|
Leukemia, Prolymphocytic, B-Cell | 2 | 2021 | 7 | 1.250 |
Why?
|
Leukemia, Erythroblastic, Acute | 8 | 2022 | 118 | 1.250 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 13 | 2020 | 482 | 1.240 |
Why?
|
Chromosomes, Human, Pair 3 | 11 | 2020 | 311 | 1.220 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 35 | 2019 | 864 | 1.220 |
Why?
|
Mediastinal Neoplasms | 8 | 2022 | 423 | 1.220 |
Why?
|
DNA, Neoplasm | 45 | 2018 | 1910 | 1.200 |
Why?
|
Leukemia, Large Granular Lymphocytic | 7 | 2018 | 63 | 1.200 |
Why?
|
Doxorubicin | 59 | 2021 | 3005 | 1.200 |
Why?
|
Leukemia | 14 | 2022 | 1635 | 1.190 |
Why?
|
Vincristine | 46 | 2020 | 1511 | 1.170 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 28 | 2023 | 2796 | 1.160 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 41 | 2015 | 3639 | 1.130 |
Why?
|
Testicular Neoplasms | 10 | 2022 | 529 | 1.110 |
Why?
|
Chromosome Deletion | 15 | 2017 | 1005 | 1.090 |
Why?
|
Skin | 16 | 2020 | 1259 | 1.080 |
Why?
|
B7-H1 Antigen | 9 | 2023 | 1022 | 1.070 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 10 | 2019 | 305 | 1.070 |
Why?
|
MDS1 and EVI1 Complex Locus Protein | 5 | 2021 | 52 | 1.070 |
Why?
|
CD3 Complex | 6 | 2020 | 314 | 1.050 |
Why?
|
Killer Cells, Natural | 14 | 2022 | 904 | 1.040 |
Why?
|
Disease-Free Survival | 69 | 2022 | 10001 | 1.040 |
Why?
|
Proto-Oncogene Proteins c-kit | 11 | 2019 | 479 | 1.040 |
Why?
|
Biopsy | 53 | 2021 | 3443 | 1.040 |
Why?
|
Physical Conditioning, Animal | 3 | 2021 | 112 | 1.030 |
Why?
|
Gene Expression Regulation, Leukemic | 13 | 2020 | 560 | 1.030 |
Why?
|
In Situ Hybridization | 28 | 2021 | 1037 | 1.020 |
Why?
|
DNA-Binding Proteins | 31 | 2022 | 4821 | 1.010 |
Why?
|
Survival Rate | 73 | 2022 | 12221 | 0.990 |
Why?
|
Cyclophosphamide | 49 | 2021 | 3001 | 0.980 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 13 | 2022 | 294 | 0.980 |
Why?
|
Apoptosis | 40 | 2019 | 7591 | 0.980 |
Why?
|
Langerhans Cell Sarcoma | 2 | 2021 | 15 | 0.980 |
Why?
|
Cytogenetic Analysis | 23 | 2019 | 568 | 0.960 |
Why?
|
Prednisone | 38 | 2020 | 984 | 0.960 |
Why?
|
Leukemia, B-Cell | 9 | 2016 | 117 | 0.950 |
Why?
|
Chromosomes, Human, Pair 7 | 11 | 2020 | 234 | 0.940 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 14 | 2017 | 166 | 0.940 |
Why?
|
Eosinophilia | 8 | 2023 | 176 | 0.930 |
Why?
|
Leukemia, Promyelocytic, Acute | 10 | 2022 | 430 | 0.930 |
Why?
|
Treatment Outcome | 108 | 2023 | 32848 | 0.910 |
Why?
|
Neoplasms, Multiple Primary | 13 | 2015 | 551 | 0.910 |
Why?
|
Gene Amplification | 13 | 2020 | 731 | 0.910 |
Why?
|
Immunoglobulin Heavy Chains | 22 | 2013 | 247 | 0.900 |
Why?
|
Dermatitis Herpetiformis | 1 | 2022 | 6 | 0.900 |
Why?
|
Chromosomes, Human, Pair 21 | 9 | 2020 | 104 | 0.900 |
Why?
|
Lymphatic Diseases | 8 | 2019 | 128 | 0.890 |
Why?
|
World Health Organization | 17 | 2023 | 316 | 0.890 |
Why?
|
Nerve Growth Factors | 2 | 2020 | 109 | 0.870 |
Why?
|
Time Factors | 51 | 2021 | 12926 | 0.870 |
Why?
|
Repressor Proteins | 13 | 2022 | 1664 | 0.870 |
Why?
|
Antineoplastic Agents | 52 | 2020 | 14289 | 0.870 |
Why?
|
Lymphoid Tissue | 10 | 2016 | 95 | 0.860 |
Why?
|
Lymphomatoid Papulosis | 7 | 2014 | 68 | 0.860 |
Why?
|
Philadelphia Chromosome | 15 | 2021 | 793 | 0.850 |
Why?
|
Vascular Diseases | 2 | 2022 | 246 | 0.850 |
Why?
|
Follow-Up Studies | 66 | 2021 | 14889 | 0.840 |
Why?
|
Granuloma | 2 | 2022 | 154 | 0.840 |
Why?
|
Predictive Value of Tests | 31 | 2021 | 4892 | 0.840 |
Why?
|
Chromosomes, Human, Pair 5 | 7 | 2016 | 259 | 0.830 |
Why?
|
Phenotype | 42 | 2023 | 6295 | 0.830 |
Why?
|
Neoplasm Staging | 56 | 2021 | 13658 | 0.820 |
Why?
|
Hyalin | 3 | 2019 | 17 | 0.820 |
Why?
|
Clonal Evolution | 4 | 2020 | 253 | 0.820 |
Why?
|
Kaplan-Meier Estimate | 41 | 2020 | 6207 | 0.820 |
Why?
|
Thrombocytosis | 4 | 2023 | 121 | 0.820 |
Why?
|
Paraproteins | 5 | 2015 | 39 | 0.810 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 9 | 2023 | 197 | 0.810 |
Why?
|
Neuralgia | 7 | 2021 | 251 | 0.810 |
Why?
|
Child | 99 | 2022 | 29154 | 0.800 |
Why?
|
Reed-Sternberg Cells | 15 | 2020 | 44 | 0.800 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 6 | 2015 | 38 | 0.800 |
Why?
|
Abnormal Karyotype | 10 | 2022 | 100 | 0.790 |
Why?
|
Proto-Oncogene Proteins c-met | 3 | 2020 | 419 | 0.790 |
Why?
|
RNA, Messenger | 23 | 2020 | 6150 | 0.790 |
Why?
|
Protein Kinase Inhibitors | 22 | 2023 | 4757 | 0.790 |
Why?
|
Dendritic Cells, Follicular | 3 | 2017 | 38 | 0.780 |
Why?
|
Receptors, Adenosine A2 | 1 | 2020 | 4 | 0.770 |
Why?
|
Receptor, Adenosine A1 | 1 | 2020 | 6 | 0.770 |
Why?
|
Hydroa Vacciniforme | 1 | 2020 | 6 | 0.770 |
Why?
|
Gene Dosage | 7 | 2020 | 829 | 0.770 |
Why?
|
Signal Transduction | 32 | 2020 | 11965 | 0.770 |
Why?
|
DNA Nucleotidylexotransferase | 4 | 2018 | 57 | 0.760 |
Why?
|
Immunoenzyme Techniques | 40 | 2012 | 1165 | 0.760 |
Why?
|
Hematopoietic Stem Cell Transplantation | 24 | 2023 | 6550 | 0.760 |
Why?
|
Breast Neoplasms | 21 | 2020 | 15694 | 0.750 |
Why?
|
Proto-Oncogene Proteins c-bcr | 2 | 2019 | 64 | 0.750 |
Why?
|
Disease Progression | 38 | 2023 | 6682 | 0.750 |
Why?
|
Chromosomes, Human, Pair 12 | 7 | 2020 | 185 | 0.740 |
Why?
|
Retrospective Studies | 101 | 2021 | 37905 | 0.740 |
Why?
|
Primary Myelofibrosis | 10 | 2022 | 831 | 0.740 |
Why?
|
RNA, Viral | 20 | 2021 | 671 | 0.740 |
Why?
|
Antibodies, Monoclonal | 36 | 2017 | 4367 | 0.730 |
Why?
|
Leukemia, T-Cell | 6 | 2007 | 87 | 0.730 |
Why?
|
Blotting, Western | 31 | 2015 | 3536 | 0.720 |
Why?
|
Chromosomes, Human | 6 | 2021 | 295 | 0.720 |
Why?
|
Cell Line, Tumor | 54 | 2019 | 14551 | 0.720 |
Why?
|
Kidney Neoplasms | 16 | 2015 | 3022 | 0.710 |
Why?
|
Nose Neoplasms | 5 | 2015 | 229 | 0.700 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 9 | 2011 | 41 | 0.690 |
Why?
|
Mycosis Fungoides | 10 | 2022 | 320 | 0.680 |
Why?
|
Genetic Predisposition to Disease | 22 | 2021 | 5539 | 0.680 |
Why?
|
Myelodysplastic-Myeloproliferative Diseases | 4 | 2023 | 114 | 0.670 |
Why?
|
Neoplasms | 34 | 2022 | 15193 | 0.670 |
Why?
|
Immunocompromised Host | 5 | 2018 | 698 | 0.670 |
Why?
|
Gene Expression Profiling | 27 | 2021 | 5159 | 0.670 |
Why?
|
Recurrence | 31 | 2022 | 4758 | 0.670 |
Why?
|
Cysts | 5 | 2012 | 197 | 0.660 |
Why?
|
Mastocytosis, Systemic | 6 | 2019 | 110 | 0.660 |
Why?
|
Histiocytosis, Sinus | 4 | 2022 | 86 | 0.660 |
Why?
|
Lung Neoplasms | 16 | 2023 | 11538 | 0.650 |
Why?
|
Survival Analysis | 52 | 2020 | 9180 | 0.650 |
Why?
|
T-Lymphocytes | 35 | 2021 | 3869 | 0.650 |
Why?
|
Isochromosomes | 4 | 2022 | 55 | 0.650 |
Why?
|
Transcription Factors | 27 | 2022 | 5270 | 0.640 |
Why?
|
Immunoglobulin M | 7 | 2018 | 347 | 0.630 |
Why?
|
Imidazoles | 5 | 2012 | 999 | 0.630 |
Why?
|
Immunologic Deficiency Syndromes | 2 | 2018 | 238 | 0.630 |
Why?
|
Piperazines | 10 | 2012 | 2101 | 0.630 |
Why?
|
Chromosomes, Human, Pair 16 | 8 | 2022 | 254 | 0.630 |
Why?
|
Rats, Wistar | 14 | 2021 | 562 | 0.620 |
Why?
|
Combined Modality Therapy | 38 | 2023 | 8865 | 0.600 |
Why?
|
Child, Preschool | 57 | 2021 | 16273 | 0.600 |
Why?
|
Genes, p53 | 11 | 2020 | 1090 | 0.600 |
Why?
|
Chromosome Inversion | 10 | 2022 | 182 | 0.600 |
Why?
|
Clone Cells | 19 | 2018 | 555 | 0.600 |
Why?
|
Fatal Outcome | 20 | 2019 | 829 | 0.590 |
Why?
|
Algorithms | 8 | 2020 | 3890 | 0.590 |
Why?
|
Dendritic Cells | 11 | 2022 | 1085 | 0.590 |
Why?
|
Taq Polymerase | 4 | 2006 | 13 | 0.580 |
Why?
|
Histone-Lysine N-Methyltransferase | 8 | 2020 | 461 | 0.580 |
Why?
|
Ki-67 Antigen | 21 | 2022 | 666 | 0.570 |
Why?
|
Caspases | 8 | 2007 | 661 | 0.570 |
Why?
|
Herpesvirus 8, Human | 7 | 2020 | 102 | 0.570 |
Why?
|
Molecular Diagnostic Techniques | 5 | 2018 | 332 | 0.570 |
Why?
|
Histiocytes | 10 | 2021 | 94 | 0.560 |
Why?
|
NF-kappa B | 10 | 2016 | 1549 | 0.560 |
Why?
|
Receptors, CXCR4 | 4 | 2016 | 269 | 0.560 |
Why?
|
Biomarkers | 23 | 2022 | 5047 | 0.560 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 13 | 2016 | 67 | 0.560 |
Why?
|
Adrenal Gland Neoplasms | 6 | 2012 | 489 | 0.560 |
Why?
|
Protein Kinases | 4 | 2009 | 874 | 0.560 |
Why?
|
Lymphadenopathy | 4 | 2022 | 90 | 0.550 |
Why?
|
Chromosomes, Human, Pair 19 | 6 | 2013 | 143 | 0.550 |
Why?
|
Remission Induction | 26 | 2021 | 3569 | 0.550 |
Why?
|
Herpes Simplex | 1 | 2017 | 95 | 0.550 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 8 | 2013 | 507 | 0.550 |
Why?
|
Cell Proliferation | 31 | 2018 | 7226 | 0.550 |
Why?
|
Tumor Suppressor Proteins | 8 | 2022 | 1823 | 0.550 |
Why?
|
Hematology | 4 | 2021 | 104 | 0.540 |
Why?
|
RNA, Neoplasm | 8 | 2021 | 771 | 0.540 |
Why?
|
Drug Resistance, Neoplasm | 10 | 2021 | 5178 | 0.540 |
Why?
|
Brain-Derived Neurotrophic Factor | 8 | 2021 | 176 | 0.540 |
Why?
|
T-Lymphocytes, Helper-Inducer | 3 | 2020 | 212 | 0.530 |
Why?
|
Chromosomes, Human, Pair 2 | 7 | 2011 | 172 | 0.530 |
Why?
|
Adenoma, Oxyphilic | 4 | 1999 | 82 | 0.520 |
Why?
|
Bone Neoplasms | 8 | 2017 | 2576 | 0.520 |
Why?
|
Trans-Activators | 11 | 2013 | 1555 | 0.520 |
Why?
|
Karyotype | 11 | 2023 | 234 | 0.520 |
Why?
|
CD8-Positive T-Lymphocytes | 8 | 2021 | 1586 | 0.510 |
Why?
|
Cystadenofibroma | 1 | 2014 | 1 | 0.510 |
Why?
|
Genomics | 9 | 2023 | 2738 | 0.510 |
Why?
|
Cytogenetics | 10 | 2021 | 149 | 0.510 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2017 | 370 | 0.510 |
Why?
|
Receptors, IgE | 6 | 2019 | 39 | 0.510 |
Why?
|
Finger Phalanges | 1 | 2014 | 6 | 0.510 |
Why?
|
Transcriptome | 13 | 2023 | 1859 | 0.510 |
Why?
|
Carrier Proteins | 9 | 2016 | 2022 | 0.500 |
Why?
|
Neoplasms, Plasma Cell | 3 | 2021 | 24 | 0.500 |
Why?
|
Proto-Oncogene Proteins B-raf | 8 | 2023 | 1283 | 0.500 |
Why?
|
Erythroid Cells | 3 | 2016 | 49 | 0.500 |
Why?
|
SOXC Transcription Factors | 3 | 2023 | 53 | 0.500 |
Why?
|
Proto-Oncogene Proteins c-akt | 12 | 2018 | 2054 | 0.500 |
Why?
|
Phosphorylation | 29 | 2019 | 4804 | 0.500 |
Why?
|
Polycythemia Vera | 4 | 2019 | 238 | 0.500 |
Why?
|
Carcinoma, Renal Cell | 11 | 2015 | 2326 | 0.490 |
Why?
|
Cell Nucleus | 18 | 2011 | 1620 | 0.490 |
Why?
|
STAT3 Transcription Factor | 14 | 2020 | 1121 | 0.490 |
Why?
|
Sensitivity and Specificity | 26 | 2019 | 4971 | 0.490 |
Why?
|
Chromosomes, Human, Pair 22 | 3 | 2017 | 169 | 0.480 |
Why?
|
Positron-Emission Tomography | 9 | 2018 | 2173 | 0.480 |
Why?
|
Biopsy, Fine-Needle | 8 | 2020 | 690 | 0.480 |
Why?
|
Tumor Cells, Cultured | 26 | 2014 | 5395 | 0.480 |
Why?
|
Cytoplasm | 10 | 2010 | 652 | 0.480 |
Why?
|
Mast Cells | 6 | 2019 | 223 | 0.480 |
Why?
|
Pyrimidines | 12 | 2020 | 3518 | 0.470 |
Why?
|
Cell Cycle | 14 | 2013 | 2084 | 0.470 |
Why?
|
Immunoblastic Lymphadenopathy | 6 | 2016 | 30 | 0.470 |
Why?
|
Chromosomes, Human, Pair 20 | 4 | 2015 | 64 | 0.470 |
Why?
|
Electrophoresis, Capillary | 4 | 2011 | 31 | 0.470 |
Why?
|
HSP90 Heat-Shock Proteins | 4 | 2012 | 196 | 0.460 |
Why?
|
Lymphadenitis | 3 | 2011 | 39 | 0.460 |
Why?
|
Adenolymphoma | 3 | 2000 | 27 | 0.460 |
Why?
|
DNA Copy Number Variations | 9 | 2022 | 1516 | 0.460 |
Why?
|
Peroxidase | 7 | 2019 | 132 | 0.450 |
Why?
|
Chronic Pain | 3 | 2021 | 238 | 0.450 |
Why?
|
Sequence Analysis, DNA | 12 | 2019 | 2483 | 0.450 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2013 | 31 | 0.450 |
Why?
|
Oncogene Fusion | 5 | 2021 | 63 | 0.450 |
Why?
|
Neoplasm Grading | 9 | 2021 | 1742 | 0.450 |
Why?
|
Paraproteinemias | 5 | 2015 | 61 | 0.440 |
Why?
|
Oligonucleotide Array Sequence Analysis | 19 | 2016 | 2508 | 0.440 |
Why?
|
Reproducibility of Results | 22 | 2021 | 6009 | 0.440 |
Why?
|
Adrenal Cortex Neoplasms | 8 | 1998 | 223 | 0.440 |
Why?
|
Gene Fusion | 4 | 2023 | 209 | 0.440 |
Why?
|
Social Media | 3 | 2021 | 203 | 0.440 |
Why?
|
Fibrocystic Breast Disease | 1 | 2012 | 45 | 0.440 |
Why?
|
Inhibitor of Apoptosis Proteins | 4 | 2015 | 202 | 0.430 |
Why?
|
Molecular Biology | 3 | 2006 | 176 | 0.430 |
Why?
|
Histiocytosis | 4 | 2020 | 54 | 0.430 |
Why?
|
Parotid Neoplasms | 3 | 2000 | 148 | 0.430 |
Why?
|
Core Binding Factor beta Subunit | 4 | 2022 | 46 | 0.420 |
Why?
|
Histiocytic Necrotizing Lymphadenitis | 2 | 2020 | 9 | 0.420 |
Why?
|
Leukemia, Lymphoid | 4 | 2016 | 276 | 0.420 |
Why?
|
Adenine | 6 | 2021 | 631 | 0.420 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2020 | 1033 | 0.420 |
Why?
|
Isocitrate Dehydrogenase | 6 | 2015 | 480 | 0.420 |
Why?
|
Specimen Handling | 4 | 2023 | 299 | 0.410 |
Why?
|
Bone Marrow Examination | 9 | 2018 | 153 | 0.410 |
Why?
|
Leukemia, Hairy Cell | 5 | 2018 | 115 | 0.410 |
Why?
|
Breast Neoplasms, Male | 4 | 2018 | 229 | 0.410 |
Why?
|
MAP Kinase Kinase 1 | 3 | 2017 | 160 | 0.410 |
Why?
|
Cell Cycle Proteins | 16 | 2014 | 2045 | 0.410 |
Why?
|
Blotting, Southern | 14 | 2010 | 406 | 0.400 |
Why?
|
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2 | 2022 | 118 | 0.400 |
Why?
|
Molecular Targeted Therapy | 10 | 2020 | 2330 | 0.400 |
Why?
|
Food Safety | 1 | 2011 | 7 | 0.390 |
Why?
|
Transplantation Conditioning | 8 | 2022 | 2238 | 0.390 |
Why?
|
Texas | 21 | 2021 | 6311 | 0.390 |
Why?
|
Dietetics | 1 | 2011 | 22 | 0.390 |
Why?
|
Piperidines | 7 | 2021 | 1035 | 0.390 |
Why?
|
Ovarian Neoplasms | 7 | 2014 | 4638 | 0.390 |
Why?
|
Gene Deletion | 6 | 2020 | 1442 | 0.380 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 9 | 2023 | 1331 | 0.380 |
Why?
|
Scholarly Communication | 2 | 2020 | 19 | 0.380 |
Why?
|
Immunoglobulin Variable Region | 9 | 2015 | 173 | 0.380 |
Why?
|
Lymphoma, Large-Cell, Immunoblastic | 4 | 2011 | 18 | 0.380 |
Why?
|
Neoplasm Recurrence, Local | 17 | 2024 | 10035 | 0.380 |
Why?
|
Liver Neoplasms | 11 | 2017 | 4557 | 0.380 |
Why?
|
Rats | 15 | 2021 | 6086 | 0.380 |
Why?
|
Antigens, CD7 | 2 | 2020 | 23 | 0.370 |
Why?
|
Genetic Testing | 7 | 2019 | 1589 | 0.370 |
Why?
|
Sequence Deletion | 8 | 2022 | 875 | 0.370 |
Why?
|
Benzamides | 9 | 2018 | 1832 | 0.370 |
Why?
|
Creatine Kinase | 6 | 1989 | 92 | 0.370 |
Why?
|
Pathology | 2 | 2021 | 101 | 0.370 |
Why?
|
Animals | 51 | 2021 | 59536 | 0.360 |
Why?
|
Pathologists | 2 | 2020 | 91 | 0.360 |
Why?
|
Acute Disease | 15 | 2024 | 2422 | 0.360 |
Why?
|
Antigens, Neoplasm | 16 | 2017 | 1506 | 0.360 |
Why?
|
Fluorescent Antibody Technique | 9 | 2019 | 1062 | 0.360 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 5 | 2016 | 173 | 0.360 |
Why?
|
Cohort Studies | 18 | 2020 | 9244 | 0.360 |
Why?
|
Phosphoproteins | 8 | 2021 | 1152 | 0.350 |
Why?
|
Janus Kinase 3 | 5 | 2023 | 46 | 0.350 |
Why?
|
Cyclins | 8 | 2007 | 456 | 0.350 |
Why?
|
Chromosome Disorders | 5 | 2010 | 417 | 0.350 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2010 | 311 | 0.350 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2009 | 100 | 0.350 |
Why?
|
CREB-Binding Protein | 2 | 2020 | 86 | 0.350 |
Why?
|
Cell Division | 17 | 2004 | 2489 | 0.340 |
Why?
|
Immunoglobulins | 8 | 2020 | 266 | 0.340 |
Why?
|
Pyrazoles | 6 | 2020 | 1471 | 0.340 |
Why?
|
Chromosomes, Human, Pair 17 | 7 | 2021 | 641 | 0.340 |
Why?
|
Thymoma | 3 | 2003 | 246 | 0.340 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 6 | 2012 | 47 | 0.340 |
Why?
|
Exons | 7 | 2019 | 1328 | 0.340 |
Why?
|
Receptors, Androgen | 2 | 2016 | 878 | 0.340 |
Why?
|
Viral Matrix Proteins | 9 | 2006 | 201 | 0.340 |
Why?
|
Proportional Hazards Models | 16 | 2020 | 4988 | 0.340 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 7 | 2020 | 102 | 0.340 |
Why?
|
Hedgehog Proteins | 5 | 2013 | 424 | 0.340 |
Why?
|
Aneuploidy | 6 | 2019 | 369 | 0.330 |
Why?
|
Biological Products | 2 | 2023 | 274 | 0.330 |
Why?
|
Composite Lymphoma | 3 | 2013 | 15 | 0.330 |
Why?
|
Sialic Acid Binding Ig-like Lectin 3 | 3 | 2019 | 83 | 0.330 |
Why?
|
Head and Neck Neoplasms | 9 | 2013 | 3976 | 0.330 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2020 | 1209 | 0.330 |
Why?
|
Proto-Oncogene Proteins c-jun | 2 | 2007 | 166 | 0.330 |
Why?
|
Radiotherapy | 10 | 2019 | 1824 | 0.330 |
Why?
|
Spleen | 11 | 2016 | 676 | 0.330 |
Why?
|
NM23 Nucleoside Diphosphate Kinases | 1 | 2008 | 13 | 0.330 |
Why?
|
Gene Expression | 11 | 2019 | 3570 | 0.330 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 7 | 2013 | 134 | 0.330 |
Why?
|
Imatinib Mesylate | 7 | 2018 | 1665 | 0.330 |
Why?
|
Programmed Cell Death 1 Receptor | 6 | 2023 | 1048 | 0.330 |
Why?
|
Vegetables | 1 | 2011 | 325 | 0.330 |
Why?
|
Immunoglobulin lambda-Chains | 3 | 2021 | 41 | 0.320 |
Why?
|
Sezary Syndrome | 5 | 2020 | 159 | 0.320 |
Why?
|
DNA (Cytosine-5-)-Methyltransferases | 3 | 2018 | 310 | 0.320 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 3 | 2020 | 105 | 0.320 |
Why?
|
Spinal Cord | 6 | 2020 | 690 | 0.320 |
Why?
|
Precursor Cells, B-Lymphoid | 2 | 2019 | 35 | 0.320 |
Why?
|
Acetylcholinesterase | 2 | 2020 | 23 | 0.320 |
Why?
|
Stomach Neoplasms | 5 | 2019 | 2278 | 0.320 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2018 | 96 | 0.320 |
Why?
|
Leukemia, Myelomonocytic, Acute | 6 | 2007 | 72 | 0.310 |
Why?
|
Risk Factors | 25 | 2021 | 17523 | 0.310 |
Why?
|
Receptors, Antigen, T-Cell | 11 | 2016 | 1146 | 0.310 |
Why?
|
Antigens, CD34 | 7 | 2022 | 593 | 0.310 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 10 | 2012 | 36 | 0.310 |
Why?
|
Leukocyte Common Antigens | 5 | 2020 | 188 | 0.310 |
Why?
|
Proteins | 3 | 2014 | 1963 | 0.310 |
Why?
|
Muramidase | 6 | 2013 | 110 | 0.310 |
Why?
|
Immunoconjugates | 2 | 2023 | 279 | 0.310 |
Why?
|
Keratins | 7 | 2000 | 330 | 0.300 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 2 | 2020 | 153 | 0.300 |
Why?
|
Immunoglobulin Light Chains | 6 | 2010 | 109 | 0.300 |
Why?
|
Receptors, Erythropoietin | 2 | 2020 | 70 | 0.300 |
Why?
|
Pathology, Molecular | 2 | 2020 | 128 | 0.300 |
Why?
|
Cytarabine | 15 | 2018 | 1973 | 0.300 |
Why?
|
Iatrogenic Disease | 3 | 2013 | 183 | 0.300 |
Why?
|
Genetic Association Studies | 4 | 2020 | 1084 | 0.300 |
Why?
|
MicroRNAs | 10 | 2018 | 2947 | 0.300 |
Why?
|
Transplantation, Homologous | 13 | 2021 | 2843 | 0.290 |
Why?
|
Education, Medical | 2 | 2021 | 331 | 0.290 |
Why?
|
Morphine | 2 | 2020 | 308 | 0.290 |
Why?
|
Etoposide | 10 | 2018 | 870 | 0.290 |
Why?
|
Lymphoma, Primary Effusion | 2 | 2020 | 13 | 0.290 |
Why?
|
STAT5 Transcription Factor | 4 | 2023 | 214 | 0.290 |
Why?
|
Age Factors | 18 | 2021 | 5377 | 0.290 |
Why?
|
Tissue Array Analysis | 11 | 2016 | 760 | 0.290 |
Why?
|
Papillomavirus Vaccines | 1 | 2009 | 195 | 0.290 |
Why?
|
Dexamethasone | 12 | 2019 | 1450 | 0.290 |
Why?
|
Thyroid Gland | 3 | 2019 | 355 | 0.280 |
Why?
|
Real-Time Polymerase Chain Reaction | 9 | 2017 | 1217 | 0.280 |
Why?
|
Chromosomes, Human, Pair 4 | 2 | 2020 | 108 | 0.280 |
Why?
|
Neoplasm, Residual | 11 | 2021 | 1656 | 0.280 |
Why?
|
Appendicitis | 2 | 2005 | 169 | 0.280 |
Why?
|
Surface Properties | 3 | 2021 | 180 | 0.280 |
Why?
|
Genital Neoplasms, Male | 2 | 2006 | 44 | 0.280 |
Why?
|
Anemia, Refractory | 3 | 2011 | 39 | 0.280 |
Why?
|
Caspase 3 | 5 | 2006 | 471 | 0.280 |
Why?
|
WT1 Proteins | 2 | 2012 | 106 | 0.280 |
Why?
|
Neoplasms, Radiation-Induced | 3 | 2015 | 388 | 0.280 |
Why?
|
Antineoplastic Agents, Immunological | 4 | 2020 | 1249 | 0.270 |
Why?
|
Cell-Free Nucleic Acids | 2 | 2019 | 224 | 0.270 |
Why?
|
GTP Phosphohydrolases | 2 | 2019 | 336 | 0.270 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 6 | 2011 | 528 | 0.270 |
Why?
|
Dipeptidyl Peptidase 4 | 2 | 2020 | 54 | 0.270 |
Why?
|
Skin Diseases | 2 | 2020 | 349 | 0.270 |
Why?
|
Pleura | 1 | 2006 | 127 | 0.270 |
Why?
|
Sequence Analysis, RNA | 4 | 2023 | 651 | 0.270 |
Why?
|
Anemia, Sideroblastic | 2 | 2019 | 58 | 0.260 |
Why?
|
Carcinoma | 7 | 2009 | 2578 | 0.260 |
Why?
|
Appendix | 1 | 2005 | 41 | 0.260 |
Why?
|
Spermatic Cord | 2 | 2002 | 14 | 0.260 |
Why?
|
In Situ Nick-End Labeling | 8 | 2006 | 448 | 0.260 |
Why?
|
Genotype | 11 | 2017 | 4109 | 0.260 |
Why?
|
Receptors, Interleukin-2 | 2 | 2005 | 186 | 0.260 |
Why?
|
Mutation, Missense | 5 | 2021 | 1152 | 0.260 |
Why?
|
Myeloid Cells | 3 | 2016 | 269 | 0.260 |
Why?
|
Databases, Factual | 7 | 2021 | 2218 | 0.260 |
Why?
|
Workflow | 4 | 2019 | 275 | 0.260 |
Why?
|
Thyroid Diseases | 1 | 2005 | 85 | 0.260 |
Why?
|
Inflammation | 4 | 2020 | 2522 | 0.260 |
Why?
|
Splenic Diseases | 2 | 2016 | 56 | 0.250 |
Why?
|
Bridged Bicyclo Compounds, Heterocyclic | 3 | 2020 | 923 | 0.250 |
Why?
|
ras Proteins | 5 | 2014 | 770 | 0.250 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2019 | 992 | 0.250 |
Why?
|
Tissue Embedding | 2 | 2015 | 28 | 0.250 |
Why?
|
Mammaplasty | 1 | 2012 | 780 | 0.250 |
Why?
|
Hematopoietic Stem Cells | 7 | 2017 | 1242 | 0.250 |
Why?
|
Poly(A)-Binding Proteins | 3 | 2015 | 32 | 0.250 |
Why?
|
Glycoproteins | 6 | 2005 | 747 | 0.250 |
Why?
|
Transplantation, Autologous | 9 | 2023 | 1914 | 0.250 |
Why?
|
Tissue Donors | 2 | 2021 | 769 | 0.250 |
Why?
|
Hippocampus | 3 | 2015 | 915 | 0.250 |
Why?
|
TOR Serine-Threonine Kinases | 7 | 2012 | 1546 | 0.250 |
Why?
|
Precision Medicine | 3 | 2017 | 1154 | 0.250 |
Why?
|
Lymphocytosis | 5 | 2023 | 58 | 0.250 |
Why?
|
Interleukin-10 | 7 | 2021 | 478 | 0.250 |
Why?
|
Radiotherapy, Adjuvant | 8 | 2016 | 2231 | 0.250 |
Why?
|
Neurofibroma | 2 | 1999 | 31 | 0.250 |
Why?
|
Pancytopenia | 2 | 2017 | 120 | 0.250 |
Why?
|
Pheochromocytoma | 4 | 1995 | 281 | 0.240 |
Why?
|
Receptors, Antigen, B-Cell | 3 | 2018 | 171 | 0.240 |
Why?
|
Adenosine | 2 | 2020 | 289 | 0.240 |
Why?
|
Myeloid Differentiation Factor 88 | 3 | 2020 | 155 | 0.240 |
Why?
|
Central Nervous System Neoplasms | 5 | 2018 | 502 | 0.240 |
Why?
|
Tumor Virus Infections | 2 | 2004 | 224 | 0.240 |
Why?
|
Terminology as Topic | 6 | 2012 | 414 | 0.240 |
Why?
|
Mitochondrial Proteins | 1 | 2006 | 369 | 0.240 |
Why?
|
Ribosomal Proteins | 2 | 2002 | 118 | 0.240 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 2 | 2022 | 47 | 0.240 |
Why?
|
Apoptosis Regulatory Proteins | 5 | 2011 | 621 | 0.240 |
Why?
|
Chromosome Breakage | 2 | 2003 | 226 | 0.240 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2023 | 5319 | 0.240 |
Why?
|
Leukosialin | 4 | 2013 | 16 | 0.230 |
Why?
|
Receptor, Notch1 | 2 | 2022 | 218 | 0.230 |
Why?
|
Orbital Neoplasms | 3 | 2010 | 224 | 0.230 |
Why?
|
DNA Primers | 12 | 2011 | 1399 | 0.230 |
Why?
|
Point Mutation | 5 | 2013 | 769 | 0.230 |
Why?
|
Genetic Variation | 6 | 2021 | 2086 | 0.230 |
Why?
|
Biopsy, Needle | 10 | 2015 | 1363 | 0.230 |
Why?
|
Retinoblastoma Protein | 2 | 2004 | 335 | 0.230 |
Why?
|
Immunosuppressive Agents | 7 | 2016 | 1375 | 0.230 |
Why?
|
Diploidy | 3 | 2018 | 114 | 0.230 |
Why?
|
Graft vs Host Disease | 5 | 2022 | 2638 | 0.230 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 6 | 2003 | 47 | 0.230 |
Why?
|
Immunoglobulin kappa-Chains | 5 | 2012 | 73 | 0.220 |
Why?
|
Tumor Microenvironment | 6 | 2020 | 2864 | 0.220 |
Why?
|
Leukocytes | 5 | 1999 | 422 | 0.220 |
Why?
|
Cell Count | 6 | 2022 | 508 | 0.220 |
Why?
|
Locomotion | 2 | 2021 | 84 | 0.220 |
Why?
|
PTEN Phosphohydrolase | 3 | 2018 | 986 | 0.220 |
Why?
|
Methotrexate | 7 | 2018 | 999 | 0.220 |
Why?
|
Tongue | 2 | 2021 | 77 | 0.220 |
Why?
|
Drug Administration Schedule | 11 | 2018 | 3472 | 0.220 |
Why?
|
Disease Models, Animal | 12 | 2021 | 7222 | 0.220 |
Why?
|
Sulfonamides | 4 | 2020 | 1823 | 0.220 |
Why?
|
STAT Transcription Factors | 1 | 2022 | 79 | 0.220 |
Why?
|
Neprilysin | 6 | 2014 | 66 | 0.220 |
Why?
|
Chromosomes, Human, Pair 13 | 4 | 2013 | 141 | 0.220 |
Why?
|
Neurosurgery | 1 | 2023 | 108 | 0.220 |
Why?
|
Treatment Failure | 10 | 2018 | 1391 | 0.220 |
Why?
|
Oncogene Proteins | 4 | 2021 | 354 | 0.210 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2022 | 328 | 0.210 |
Why?
|
Pain Threshold | 3 | 2017 | 130 | 0.210 |
Why?
|
Microarray Analysis | 2 | 2021 | 392 | 0.210 |
Why?
|
Device Removal | 3 | 2013 | 337 | 0.210 |
Why?
|
Uterine Cervical Diseases | 2 | 2011 | 25 | 0.210 |
Why?
|
Narcotic Antagonists | 2 | 2020 | 129 | 0.210 |
Why?
|
Esophageal Neoplasms | 2 | 2015 | 3168 | 0.210 |
Why?
|
Bone Marrow Diseases | 3 | 2015 | 177 | 0.210 |
Why?
|
Hepatomegaly | 3 | 2016 | 69 | 0.210 |
Why?
|
Pleural Neoplasms | 1 | 2006 | 470 | 0.210 |
Why?
|
Topoisomerase II Inhibitors | 2 | 2020 | 58 | 0.210 |
Why?
|
Protein Isoforms | 1 | 2004 | 842 | 0.210 |
Why?
|
Brain | 7 | 2020 | 4113 | 0.210 |
Why?
|
Cytodiagnosis | 2 | 2020 | 220 | 0.210 |
Why?
|
Breast | 5 | 2018 | 1344 | 0.210 |
Why?
|
Chemoradiotherapy | 4 | 2019 | 1946 | 0.210 |
Why?
|
Janus Kinase Inhibitors | 1 | 2022 | 63 | 0.210 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 2002 | 73 | 0.200 |
Why?
|
Genital Neoplasms, Female | 2 | 2006 | 735 | 0.200 |
Why?
|
Autoimmune Diseases | 3 | 2013 | 402 | 0.200 |
Why?
|
Myeloablative Agonists | 3 | 2015 | 384 | 0.200 |
Why?
|
Liquid Biopsy | 2 | 2019 | 158 | 0.200 |
Why?
|
DEAD-box RNA Helicases | 2 | 2023 | 255 | 0.200 |
Why?
|
Chronic Disease | 7 | 2024 | 1819 | 0.200 |
Why?
|
Molecular Chaperones | 1 | 2002 | 264 | 0.200 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 4 | 2022 | 460 | 0.200 |
Why?
|
Interferon Regulatory Factors | 2 | 2019 | 76 | 0.200 |
Why?
|
Prosthesis Design | 2 | 2021 | 749 | 0.200 |
Why?
|
False Negative Reactions | 3 | 2015 | 275 | 0.200 |
Why?
|
Tonsillar Neoplasms | 1 | 2021 | 80 | 0.200 |
Why?
|
Immunoglobulin G | 4 | 2016 | 1021 | 0.200 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2016 | 4549 | 0.200 |
Why?
|
Adenoma | 6 | 2005 | 716 | 0.200 |
Why?
|
Cytokines | 5 | 2020 | 2809 | 0.190 |
Why?
|
Neutrophils | 5 | 2012 | 835 | 0.190 |
Why?
|
Computational Biology | 3 | 2019 | 1271 | 0.190 |
Why?
|
Pathology, Clinical | 3 | 2018 | 152 | 0.190 |
Why?
|
Information Dissemination | 2 | 2020 | 272 | 0.190 |
Why?
|
Myeloid Progenitor Cells | 1 | 2021 | 49 | 0.190 |
Why?
|
Vinblastine | 6 | 2012 | 453 | 0.190 |
Why?
|
Langerhans Cells | 1 | 2021 | 50 | 0.190 |
Why?
|
Myeloid Cell Leukemia Sequence 1 Protein | 5 | 2012 | 275 | 0.190 |
Why?
|
Chromosomes, Human, Pair 9 | 3 | 2021 | 290 | 0.190 |
Why?
|
Granuloma, Plasma Cell | 4 | 2000 | 38 | 0.190 |
Why?
|
Sarcoidosis | 1 | 2002 | 112 | 0.190 |
Why?
|
Papillomavirus Infections | 1 | 2009 | 980 | 0.190 |
Why?
|
Lactams, Macrocyclic | 3 | 2012 | 90 | 0.190 |
Why?
|
Clinical Laboratory Services | 2 | 2018 | 42 | 0.190 |
Why?
|
Serine-Arginine Splicing Factors | 2 | 2022 | 88 | 0.190 |
Why?
|
Alcohol Abstinence | 1 | 2020 | 17 | 0.190 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2020 | 37 | 0.190 |
Why?
|
Immunoprecipitation | 4 | 2012 | 591 | 0.190 |
Why?
|
Benzoquinones | 3 | 2012 | 108 | 0.190 |
Why?
|
Chromosome Fragility | 1 | 2000 | 33 | 0.190 |
Why?
|
Pleural Diseases | 1 | 2001 | 57 | 0.190 |
Why?
|
Lipoprotein Lipase | 1 | 2020 | 52 | 0.190 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2017 | 182 | 0.190 |
Why?
|
Adrenal Gland Diseases | 3 | 1990 | 72 | 0.190 |
Why?
|
Cell Dedifferentiation | 1 | 2021 | 96 | 0.190 |
Why?
|
Chromosomes, Human, Pair 15 | 3 | 2014 | 231 | 0.190 |
Why?
|
Bowen's Disease | 1 | 2000 | 10 | 0.190 |
Why?
|
Receptors, Cytokine | 1 | 2021 | 176 | 0.190 |
Why?
|
Receptors, Cell Surface | 3 | 2013 | 862 | 0.190 |
Why?
|
Attitude to Computers | 1 | 2020 | 71 | 0.190 |
Why?
|
Jejunal Neoplasms | 2 | 1999 | 34 | 0.190 |
Why?
|
Magnetic Resonance Imaging | 5 | 2014 | 7702 | 0.190 |
Why?
|
Receptors, Cholinergic | 1 | 2020 | 84 | 0.190 |
Why?
|
Cytological Techniques | 1 | 2020 | 74 | 0.190 |
Why?
|
Infant | 22 | 2020 | 13310 | 0.190 |
Why?
|
Pyrazines | 3 | 2018 | 495 | 0.190 |
Why?
|
Phosphatidylinositol 3-Kinases | 6 | 2018 | 1678 | 0.190 |
Why?
|
False Positive Reactions | 4 | 2019 | 355 | 0.180 |
Why?
|
Education, Distance | 1 | 2021 | 93 | 0.180 |
Why?
|
Splenomegaly | 3 | 2017 | 158 | 0.180 |
Why?
|
Granular Cell Tumor | 1 | 2000 | 22 | 0.180 |
Why?
|
Cell Transdifferentiation | 1 | 2021 | 112 | 0.180 |
Why?
|
Trigeminal Neuralgia | 1 | 2020 | 42 | 0.180 |
Why?
|
Hemangiosarcoma | 2 | 2013 | 234 | 0.180 |
Why?
|
Naltrexone | 1 | 2020 | 87 | 0.180 |
Why?
|
Splenectomy | 3 | 2020 | 158 | 0.180 |
Why?
|
Skin Ulcer | 1 | 2020 | 77 | 0.180 |
Why?
|
Salvage Therapy | 4 | 2019 | 2054 | 0.180 |
Why?
|
Radiography | 6 | 2014 | 1904 | 0.180 |
Why?
|
Stromal Cells | 4 | 2013 | 825 | 0.180 |
Why?
|
Paget Disease, Extramammary | 1 | 2000 | 55 | 0.180 |
Why?
|
Tongue Neoplasms | 1 | 2021 | 246 | 0.180 |
Why?
|
Adaptor Proteins, Signal Transducing | 6 | 2012 | 1439 | 0.180 |
Why?
|
Analgesics | 2 | 2020 | 390 | 0.180 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 2 | 2013 | 65 | 0.180 |
Why?
|
Skin Abnormalities | 1 | 2019 | 23 | 0.180 |
Why?
|
Eye Diseases, Hereditary | 1 | 2019 | 36 | 0.180 |
Why?
|
Enzyme Activation | 7 | 2009 | 1764 | 0.170 |
Why?
|
PAX5 Transcription Factor | 2 | 2011 | 45 | 0.170 |
Why?
|
Base Sequence | 14 | 2014 | 4917 | 0.170 |
Why?
|
Receptors, Thrombopoietin | 2 | 2019 | 65 | 0.170 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2000 | 137 | 0.170 |
Why?
|
Disease Susceptibility | 2 | 2021 | 538 | 0.170 |
Why?
|
POEMS Syndrome | 1 | 2019 | 22 | 0.170 |
Why?
|
Neoplastic Stem Cells | 6 | 2014 | 1443 | 0.170 |
Why?
|
Retroperitoneal Neoplasms | 2 | 2019 | 262 | 0.170 |
Why?
|
Exodeoxyribonucleases | 1 | 1999 | 104 | 0.170 |
Why?
|
Colorectal Neoplasms | 3 | 2023 | 3578 | 0.170 |
Why?
|
Ikaros Transcription Factor | 2 | 2017 | 54 | 0.170 |
Why?
|
T-Cell Intracellular Antigen-1 | 3 | 2015 | 16 | 0.170 |
Why?
|
ROC Curve | 3 | 2020 | 1183 | 0.170 |
Why?
|
Yttrium Radioisotopes | 2 | 2018 | 178 | 0.170 |
Why?
|
Interleukin-3 Receptor alpha Subunit | 2 | 2018 | 106 | 0.170 |
Why?
|
Incidental Findings | 3 | 2021 | 272 | 0.170 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2012 | 612 | 0.170 |
Why?
|
Protein Array Analysis | 4 | 2005 | 501 | 0.170 |
Why?
|
Gastrointestinal Neoplasms | 4 | 2014 | 600 | 0.170 |
Why?
|
Multivariate Analysis | 11 | 2017 | 4298 | 0.170 |
Why?
|
Vidarabine | 6 | 2016 | 1341 | 0.170 |
Why?
|
Transcription, Genetic | 10 | 2020 | 3154 | 0.170 |
Why?
|
Anxiety | 3 | 2022 | 1179 | 0.170 |
Why?
|
Mice, SCID | 6 | 2017 | 1869 | 0.170 |
Why?
|
Epidermis | 2 | 2017 | 188 | 0.170 |
Why?
|
Interleukin-6 | 3 | 2019 | 1038 | 0.170 |
Why?
|
Transcription Factor RelA | 4 | 2007 | 184 | 0.170 |
Why?
|
Risk Assessment | 11 | 2020 | 6869 | 0.170 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2019 | 703 | 0.170 |
Why?
|
Down-Regulation | 9 | 2018 | 2074 | 0.170 |
Why?
|
Leukemia, Biphenotypic, Acute | 2 | 2016 | 52 | 0.160 |
Why?
|
Germ-Line Mutation | 3 | 2019 | 1046 | 0.160 |
Why?
|
Hemangioendothelioma | 1 | 1998 | 35 | 0.160 |
Why?
|
Education, Medical, Continuing | 1 | 2020 | 251 | 0.160 |
Why?
|
DNA | 8 | 2014 | 2693 | 0.160 |
Why?
|
Orbital Diseases | 2 | 1989 | 118 | 0.160 |
Why?
|
Vascular Neoplasms | 1 | 1999 | 114 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2018 | 79 | 0.160 |
Why?
|
Chemotherapy-Induced Febrile Neutropenia | 1 | 2018 | 31 | 0.160 |
Why?
|
Eukaryotic Initiation Factor-4E | 2 | 2009 | 94 | 0.160 |
Why?
|
Calreticulin | 2 | 2015 | 74 | 0.160 |
Why?
|
Fibrosis | 5 | 2015 | 793 | 0.160 |
Why?
|
Intestinal Diseases | 1 | 2019 | 121 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2021 | 639 | 0.160 |
Why?
|
Caffeine | 2 | 2017 | 87 | 0.160 |
Why?
|
Diarrhea | 2 | 2019 | 686 | 0.160 |
Why?
|
S100 Proteins | 4 | 2020 | 181 | 0.160 |
Why?
|
Thyroid Nodule | 1 | 2019 | 92 | 0.160 |
Why?
|
Alcohol Drinking | 1 | 2021 | 551 | 0.160 |
Why?
|
Sciatic Nerve | 4 | 2020 | 112 | 0.160 |
Why?
|
Chromosome Mapping | 6 | 2023 | 1471 | 0.160 |
Why?
|
Models, Biological | 6 | 2018 | 3254 | 0.160 |
Why?
|
Thyroid Neoplasms | 4 | 2019 | 1866 | 0.160 |
Why?
|
Leukemic Infiltration | 3 | 2014 | 72 | 0.160 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2017 | 521 | 0.150 |
Why?
|
Membrane Proteins | 3 | 2019 | 2819 | 0.150 |
Why?
|
Immunologic Factors | 5 | 2019 | 649 | 0.150 |
Why?
|
Clinical Protocols | 2 | 2010 | 467 | 0.150 |
Why?
|
Pruritus | 1 | 2018 | 87 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 3 | 2010 | 287 | 0.150 |
Why?
|
Gene Duplication | 3 | 2010 | 421 | 0.150 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2011 | 182 | 0.150 |
Why?
|
Genetic Heterogeneity | 1 | 2019 | 318 | 0.150 |
Why?
|
Inflammation Mediators | 1 | 2020 | 423 | 0.150 |
Why?
|
CD30 Ligand | 2 | 2015 | 13 | 0.150 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2020 | 1016 | 0.150 |
Why?
|
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | 2 | 2007 | 24 | 0.150 |
Why?
|
Radiotherapy, Intensity-Modulated | 2 | 2019 | 2104 | 0.150 |
Why?
|
CTLA-4 Antigen | 2 | 2019 | 657 | 0.150 |
Why?
|
Cell Lineage | 5 | 2020 | 668 | 0.150 |
Why?
|
Dura Mater | 2 | 1996 | 73 | 0.150 |
Why?
|
Dasatinib | 2 | 2018 | 862 | 0.150 |
Why?
|
Conjunctiva | 2 | 1989 | 250 | 0.150 |
Why?
|
Thymus Neoplasms | 2 | 1993 | 400 | 0.150 |
Why?
|
Tetraploidy | 1 | 2016 | 5 | 0.150 |
Why?
|
Azaserine | 1 | 2016 | 5 | 0.150 |
Why?
|
Postoperative Complications | 5 | 2012 | 5542 | 0.150 |
Why?
|
Adenocarcinoma | 9 | 2019 | 7789 | 0.150 |
Why?
|
Stress, Psychological | 2 | 2015 | 1000 | 0.150 |
Why?
|
Radiopharmaceuticals | 4 | 2015 | 1301 | 0.150 |
Why?
|
Hexosamines | 1 | 2016 | 25 | 0.150 |
Why?
|
Acetylglucosamine | 1 | 2016 | 25 | 0.150 |
Why?
|
Organotechnetium Compounds | 1 | 2016 | 44 | 0.150 |
Why?
|
Sensory Thresholds | 1 | 2016 | 68 | 0.150 |
Why?
|
Histone Acetyltransferases | 1 | 2019 | 411 | 0.150 |
Why?
|
Bleomycin | 5 | 2012 | 467 | 0.150 |
Why?
|
Molecular Sequence Data | 11 | 2014 | 6089 | 0.140 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2016 | 46 | 0.140 |
Why?
|
MAP Kinase Signaling System | 2 | 2018 | 848 | 0.140 |
Why?
|
Central Nervous System Stimulants | 2 | 2017 | 225 | 0.140 |
Why?
|
Body Fluids | 2 | 2008 | 125 | 0.140 |
Why?
|
Adoptive Transfer | 1 | 2019 | 446 | 0.140 |
Why?
|
Drug Therapy | 2 | 2016 | 205 | 0.140 |
Why?
|
Nociception | 1 | 2016 | 45 | 0.140 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily D | 2 | 2007 | 15 | 0.140 |
Why?
|
RNAi Therapeutics | 1 | 2016 | 42 | 0.140 |
Why?
|
Incidence | 10 | 2018 | 5673 | 0.140 |
Why?
|
Rectal Neoplasms | 1 | 2005 | 1202 | 0.140 |
Why?
|
Clusterin | 2 | 2009 | 28 | 0.140 |
Why?
|
Microdissection | 5 | 2012 | 86 | 0.140 |
Why?
|
Comparative Genomic Hybridization | 3 | 2014 | 691 | 0.140 |
Why?
|
Therapeutics | 1 | 2016 | 34 | 0.140 |
Why?
|
Genes, ras | 3 | 2011 | 667 | 0.140 |
Why?
|
Uremia | 2 | 1987 | 42 | 0.140 |
Why?
|
Sex Characteristics | 1 | 2019 | 417 | 0.140 |
Why?
|
Receptors, Retinoic Acid | 2 | 2015 | 365 | 0.140 |
Why?
|
Precancerous Conditions | 2 | 2000 | 1058 | 0.140 |
Why?
|
Bendamustine Hydrochloride | 1 | 2016 | 107 | 0.140 |
Why?
|
Genes, erbB-1 | 2 | 2016 | 101 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 8 | 2018 | 7551 | 0.140 |
Why?
|
SEER Program | 3 | 2008 | 1000 | 0.140 |
Why?
|
Immune System Diseases | 1 | 2016 | 65 | 0.140 |
Why?
|
Microsatellite Instability | 2 | 2023 | 400 | 0.140 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2006 | 1265 | 0.140 |
Why?
|
Immunoglobulin gamma-Chains | 2 | 2012 | 11 | 0.140 |
Why?
|
Antigens, Differentiation | 6 | 1992 | 238 | 0.140 |
Why?
|
Membrane Glycoproteins | 8 | 2006 | 1073 | 0.140 |
Why?
|
Cytotoxins | 2 | 2017 | 66 | 0.140 |
Why?
|
Dacarbazine | 5 | 2012 | 485 | 0.140 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2018 | 221 | 0.140 |
Why?
|
Dendritic Cell Sarcoma, Interdigitating | 1 | 2015 | 4 | 0.130 |
Why?
|
Cysteine | 1 | 2016 | 214 | 0.130 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 1995 | 31 | 0.130 |
Why?
|
Plasmablastic Lymphoma | 1 | 2015 | 37 | 0.130 |
Why?
|
NF-kappa B p52 Subunit | 1 | 2015 | 26 | 0.130 |
Why?
|
Genetic Techniques | 3 | 2006 | 130 | 0.130 |
Why?
|
Meningeal Neoplasms | 1 | 2000 | 441 | 0.130 |
Why?
|
Radiotherapy Dosage | 7 | 2019 | 3842 | 0.130 |
Why?
|
Cervix Uteri | 2 | 2011 | 253 | 0.130 |
Why?
|
Liver Transplantation | 2 | 2001 | 1112 | 0.130 |
Why?
|
Inclusion Bodies | 1 | 2015 | 76 | 0.130 |
Why?
|
Curriculum | 3 | 2023 | 860 | 0.130 |
Why?
|
Remission, Spontaneous | 1 | 2015 | 119 | 0.130 |
Why?
|
Proto-Oncogenes | 3 | 2007 | 202 | 0.130 |
Why?
|
Karyopherins | 1 | 2016 | 136 | 0.130 |
Why?
|
Jurkat Cells | 5 | 2009 | 311 | 0.130 |
Why?
|
Cell Separation | 4 | 2009 | 612 | 0.130 |
Why?
|
Microscopy, Electron | 5 | 1998 | 600 | 0.130 |
Why?
|
Monosomy | 2 | 2022 | 95 | 0.130 |
Why?
|
Chromosomes, Human, X | 1 | 2016 | 192 | 0.130 |
Why?
|
TYK2 Kinase | 1 | 2014 | 9 | 0.130 |
Why?
|
Immunoglobulin A | 1 | 2015 | 237 | 0.130 |
Why?
|
Frontal Lobe | 1 | 1996 | 187 | 0.130 |
Why?
|
Gene Frequency | 5 | 2019 | 1163 | 0.130 |
Why?
|
Mucin-1 | 3 | 2003 | 127 | 0.130 |
Why?
|
Cecal Diseases | 1 | 1994 | 13 | 0.130 |
Why?
|
Cell Survival | 7 | 2015 | 3045 | 0.130 |
Why?
|
Lymphoma, Primary Cutaneous Anaplastic Large Cell | 1 | 2014 | 9 | 0.130 |
Why?
|
Amyloid | 1 | 1995 | 97 | 0.130 |
Why?
|
Gastric Mucosa | 1 | 2019 | 613 | 0.130 |
Why?
|
Hematopoiesis | 1 | 2018 | 560 | 0.130 |
Why?
|
Rhabdomyolysis | 1 | 2015 | 52 | 0.130 |
Why?
|
Orbit | 2 | 2010 | 205 | 0.130 |
Why?
|
CDC2-CDC28 Kinases | 2 | 2017 | 129 | 0.130 |
Why?
|
Stem Cells | 1 | 2002 | 1213 | 0.130 |
Why?
|
Chromosome Banding | 7 | 2011 | 256 | 0.130 |
Why?
|
Cerebral Cortex | 2 | 2015 | 621 | 0.130 |
Why?
|
Tandem Repeat Sequences | 3 | 2018 | 201 | 0.120 |
Why?
|
CD8 Antigens | 1 | 2015 | 170 | 0.120 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2015 | 134 | 0.120 |
Why?
|
Drug Synergism | 4 | 2012 | 1313 | 0.120 |
Why?
|
Analysis of Variance | 6 | 2015 | 2307 | 0.120 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 2 | 2012 | 47 | 0.120 |
Why?
|
Mastocytosis | 1 | 1994 | 21 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2014 | 123 | 0.120 |
Why?
|
Myofascial Pain Syndromes | 1 | 2014 | 9 | 0.120 |
Why?
|
Lymphocyte Activation | 5 | 2013 | 1688 | 0.120 |
Why?
|
RNA Splicing Factors | 3 | 2021 | 153 | 0.120 |
Why?
|
Memory, Short-Term | 1 | 2015 | 160 | 0.120 |
Why?
|
3' Untranslated Regions | 2 | 2013 | 343 | 0.120 |
Why?
|
Loss of Heterozygosity | 4 | 2016 | 602 | 0.120 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 669 | 0.120 |
Why?
|
Immunomodulation | 1 | 2015 | 242 | 0.120 |
Why?
|
Pyramidal Tracts | 1 | 2014 | 57 | 0.120 |
Why?
|
Antigens, CD19 | 3 | 2012 | 577 | 0.120 |
Why?
|
Lymphoma, AIDS-Related | 4 | 2005 | 70 | 0.120 |
Why?
|
Isoenzymes | 7 | 2001 | 614 | 0.120 |
Why?
|
Genes, Neoplasm | 2 | 2014 | 324 | 0.120 |
Why?
|
Melphalan | 3 | 2023 | 834 | 0.120 |
Why?
|
Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2015 | 167 | 0.120 |
Why?
|
Testicular Diseases | 1 | 1993 | 22 | 0.120 |
Why?
|
G1 Phase | 5 | 2006 | 285 | 0.120 |
Why?
|
Smad4 Protein | 1 | 2015 | 196 | 0.120 |
Why?
|
Bronchi | 1 | 2015 | 326 | 0.120 |
Why?
|
HIV Infections | 4 | 2012 | 2134 | 0.120 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2014 | 75 | 0.120 |
Why?
|
Serine | 3 | 2011 | 388 | 0.120 |
Why?
|
DNA Methylation | 3 | 2016 | 2669 | 0.120 |
Why?
|
Stroke | 1 | 2022 | 1144 | 0.120 |
Why?
|
Transcriptional Activation | 3 | 2007 | 1070 | 0.110 |
Why?
|
Mice | 16 | 2018 | 34495 | 0.110 |
Why?
|
Sialoglycoproteins | 3 | 2002 | 151 | 0.110 |
Why?
|
bcl-2-Associated X Protein | 3 | 2003 | 367 | 0.110 |
Why?
|
Longitudinal Studies | 1 | 2018 | 1945 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2018 | 4938 | 0.110 |
Why?
|
Virilism | 1 | 1992 | 15 | 0.110 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2014 | 137 | 0.110 |
Why?
|
DNA Viruses | 1 | 2013 | 48 | 0.110 |
Why?
|
Radionuclide Imaging | 1 | 2014 | 660 | 0.110 |
Why?
|
Leukocyte Count | 6 | 2012 | 684 | 0.110 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2021 | 1538 | 0.110 |
Why?
|
CD11c Antigen | 1 | 2013 | 55 | 0.110 |
Why?
|
CD11a Antigen | 1 | 2012 | 15 | 0.110 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1993 | 182 | 0.110 |
Why?
|
Thrombocythemia, Essential | 1 | 2014 | 162 | 0.110 |
Why?
|
Hydroxamic Acids | 2 | 2014 | 442 | 0.110 |
Why?
|
Memory Disorders | 1 | 2015 | 295 | 0.110 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2013 | 67 | 0.110 |
Why?
|
Cell Cycle Checkpoints | 1 | 2014 | 278 | 0.110 |
Why?
|
Thyroiditis | 1 | 1992 | 18 | 0.110 |
Why?
|
Panniculitis | 3 | 2002 | 58 | 0.110 |
Why?
|
Neoplasm Metastasis | 7 | 2015 | 5112 | 0.110 |
Why?
|
Receptor, Notch2 | 1 | 2012 | 25 | 0.110 |
Why?
|
Cytochrome P-450 CYP2E1 | 1 | 2012 | 16 | 0.110 |
Why?
|
Thyroiditis, Autoimmune | 1 | 1992 | 36 | 0.110 |
Why?
|
Diagnostic Imaging | 2 | 2014 | 1162 | 0.110 |
Why?
|
Lymphomatoid Granulomatosis | 1 | 1992 | 4 | 0.110 |
Why?
|
CD18 Antigens | 1 | 2012 | 83 | 0.110 |
Why?
|
CD56 Antigen | 2 | 2003 | 83 | 0.110 |
Why?
|
Oncogenes | 3 | 2013 | 673 | 0.110 |
Why?
|
Internship and Residency | 1 | 2023 | 1375 | 0.110 |
Why?
|
Erythroid Precursor Cells | 1 | 2012 | 61 | 0.110 |
Why?
|
Aging | 3 | 2016 | 1582 | 0.110 |
Why?
|
Histocompatibility Antigens Class I | 1 | 1993 | 235 | 0.110 |
Why?
|
Complementarity Determining Regions | 2 | 2010 | 43 | 0.110 |
Why?
|
Choristoma | 1 | 1992 | 85 | 0.110 |
Why?
|
Antigens, Surface | 6 | 2003 | 295 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-pim-1 | 1 | 2012 | 45 | 0.110 |
Why?
|
Keratinocytes | 1 | 2013 | 241 | 0.110 |
Why?
|
Genome, Human | 4 | 2016 | 1869 | 0.110 |
Why?
|
Genes, Immunoglobulin | 7 | 2003 | 87 | 0.110 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2013 | 301 | 0.110 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2015 | 274 | 0.110 |
Why?
|
ACTH Syndrome, Ectopic | 1 | 1992 | 24 | 0.110 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2012 | 83 | 0.110 |
Why?
|
Metabolic Networks and Pathways | 2 | 2016 | 336 | 0.110 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 2012 | 60 | 0.110 |
Why?
|
Sodium Chloride | 1 | 2012 | 156 | 0.110 |
Why?
|
Immunoproliferative Disorders | 1 | 1991 | 1 | 0.110 |
Why?
|
Poly A | 1 | 2012 | 87 | 0.110 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2012 | 104 | 0.110 |
Why?
|
Bronchoscopy | 1 | 2015 | 474 | 0.100 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2011 | 270 | 0.100 |
Why?
|
bcl-X Protein | 2 | 2003 | 196 | 0.100 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 591 | 0.100 |
Why?
|
Pseudolymphoma | 1 | 2011 | 22 | 0.100 |
Why?
|
Leptin | 1 | 2013 | 295 | 0.100 |
Why?
|
Genes, Viral | 1 | 1992 | 202 | 0.100 |
Why?
|
Aurora Kinase A | 1 | 2013 | 202 | 0.100 |
Why?
|
Lymphocyte Count | 3 | 2009 | 486 | 0.100 |
Why?
|
Syndrome | 2 | 2010 | 1351 | 0.100 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2014 | 268 | 0.100 |
Why?
|
Uterine Neoplasms | 3 | 2001 | 545 | 0.100 |
Why?
|
Cushing Syndrome | 1 | 1992 | 70 | 0.100 |
Why?
|
Classification | 2 | 2009 | 41 | 0.100 |
Why?
|
Enzyme Inhibitors | 3 | 2016 | 1879 | 0.100 |
Why?
|
Genetic Markers | 4 | 2017 | 974 | 0.100 |
Why?
|
Watchful Waiting | 1 | 2013 | 289 | 0.100 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2014 | 1498 | 0.100 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 2 | 2009 | 205 | 0.100 |
Why?
|
L-Lactate Dehydrogenase | 3 | 2014 | 299 | 0.100 |
Why?
|
Fas-Associated Death Domain Protein | 1 | 2011 | 25 | 0.100 |
Why?
|
Gene Regulatory Networks | 2 | 2018 | 677 | 0.100 |
Why?
|
Paired Box Transcription Factors | 1 | 2011 | 134 | 0.100 |
Why?
|
Foodborne Diseases | 1 | 2011 | 11 | 0.100 |
Why?
|
Chemotherapy, Adjuvant | 5 | 2015 | 3890 | 0.100 |
Why?
|
Motor Activity | 1 | 2015 | 693 | 0.100 |
Why?
|
Up-Regulation | 6 | 2018 | 2450 | 0.100 |
Why?
|
Erythrocytes | 2 | 1998 | 339 | 0.100 |
Why?
|
Nerve Tissue Proteins | 3 | 2011 | 1491 | 0.100 |
Why?
|
Triglycerides | 1 | 2013 | 603 | 0.100 |
Why?
|
Homeostasis | 2 | 2013 | 950 | 0.100 |
Why?
|
Staining and Labeling | 5 | 1999 | 429 | 0.100 |
Why?
|
Sex Factors | 5 | 2019 | 2139 | 0.100 |
Why?
|
Pain Measurement | 4 | 2015 | 953 | 0.100 |
Why?
|
B-Cell Activation Factor Receptor | 1 | 2010 | 24 | 0.100 |
Why?
|
ADP-ribosyl Cyclase 1 | 5 | 2010 | 141 | 0.100 |
Why?
|
Retreatment | 3 | 2018 | 452 | 0.100 |
Why?
|
Leukemia, Myeloid, Chronic-Phase | 2 | 2006 | 505 | 0.100 |
Why?
|
Quality Improvement | 1 | 2018 | 851 | 0.100 |
Why?
|
Thiazoles | 1 | 2015 | 726 | 0.100 |
Why?
|
Morpholines | 4 | 2017 | 289 | 0.100 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 2 | 2011 | 119 | 0.100 |
Why?
|
Idarubicin | 5 | 2014 | 446 | 0.090 |
Why?
|
Macrophages | 2 | 2020 | 1304 | 0.090 |
Why?
|
Receptors, Transferrin | 2 | 1991 | 45 | 0.090 |
Why?
|
Lewis X Antigen | 2 | 2013 | 46 | 0.090 |
Why?
|
Education | 1 | 2011 | 112 | 0.090 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2010 | 131 | 0.090 |
Why?
|
CD2 Antigens | 2 | 2014 | 31 | 0.090 |
Why?
|
Vulvar Neoplasms | 2 | 2004 | 236 | 0.090 |
Why?
|
Thrombopoiesis | 1 | 2010 | 16 | 0.090 |
Why?
|
Melanoma | 3 | 2020 | 5317 | 0.090 |
Why?
|
Intention | 1 | 2011 | 109 | 0.090 |
Why?
|
DNA, Viral | 9 | 2005 | 694 | 0.090 |
Why?
|
B-Cell CLL-Lymphoma 10 Protein | 2 | 2006 | 30 | 0.090 |
Why?
|
Thymidine Kinase | 1 | 2010 | 193 | 0.090 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2009 | 32 | 0.090 |
Why?
|
Contrast Media | 1 | 2016 | 1472 | 0.090 |
Why?
|
Mice, Inbred NOD | 3 | 2017 | 905 | 0.090 |
Why?
|
Case-Control Studies | 6 | 2018 | 6100 | 0.090 |
Why?
|
Cavernous Sinus | 1 | 2010 | 33 | 0.090 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 1992 | 323 | 0.090 |
Why?
|
Sirolimus | 2 | 2012 | 814 | 0.090 |
Why?
|
Pyridazines | 1 | 2012 | 293 | 0.090 |
Why?
|
Developmental Disabilities | 1 | 2014 | 674 | 0.090 |
Why?
|
Proteomics | 4 | 2022 | 1380 | 0.090 |
Why?
|
Sclerosis | 1 | 2009 | 84 | 0.090 |
Why?
|
Blood Platelets | 2 | 1985 | 731 | 0.090 |
Why?
|
Conjunctival Diseases | 1 | 1989 | 37 | 0.090 |
Why?
|
Neuroblastoma | 2 | 2009 | 686 | 0.090 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2009 | 43 | 0.090 |
Why?
|
Thoracic Neoplasms | 1 | 1992 | 337 | 0.090 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 3 | 2010 | 33 | 0.090 |
Why?
|
Disease Management | 3 | 2021 | 1052 | 0.090 |
Why?
|
Thrombocytopenia | 2 | 2013 | 846 | 0.090 |
Why?
|
Cyclin D3 | 2 | 2007 | 23 | 0.090 |
Why?
|
Pathology, Surgical | 1 | 2010 | 81 | 0.090 |
Why?
|
United States | 9 | 2016 | 15433 | 0.090 |
Why?
|
Liver | 9 | 2022 | 2961 | 0.090 |
Why?
|
Conjunctival Neoplasms | 1 | 1990 | 120 | 0.080 |
Why?
|
Urethral Diseases | 1 | 1989 | 36 | 0.080 |
Why?
|
Lymphatic Metastasis | 6 | 2019 | 4844 | 0.080 |
Why?
|
Bone and Bones | 1 | 2012 | 619 | 0.080 |
Why?
|
Fluorescent Antibody Technique, Indirect | 3 | 2006 | 189 | 0.080 |
Why?
|
Penile Neoplasms | 1 | 2011 | 161 | 0.080 |
Why?
|
Diverticulum, Esophageal | 1 | 1988 | 5 | 0.080 |
Why?
|
Tumor Burden | 4 | 2016 | 1987 | 0.080 |
Why?
|
Diverticulum | 1 | 1989 | 35 | 0.080 |
Why?
|
Antibodies, Neoplasm | 1 | 2010 | 259 | 0.080 |
Why?
|
Teaching | 1 | 2011 | 243 | 0.080 |
Why?
|
RUNX1 Translocation Partner 1 Protein | 3 | 2019 | 37 | 0.080 |
Why?
|
Urethral Neoplasms | 1 | 1989 | 60 | 0.080 |
Why?
|
Centrifugation | 2 | 2019 | 66 | 0.080 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2008 | 31 | 0.080 |
Why?
|
RNA-Binding Proteins | 4 | 2022 | 984 | 0.080 |
Why?
|
Leukocytosis | 2 | 2023 | 112 | 0.080 |
Why?
|
Leukemia, Plasma Cell | 2 | 2006 | 42 | 0.080 |
Why?
|
Health Education | 1 | 2011 | 309 | 0.080 |
Why?
|
Sex Chromosomes | 1 | 2008 | 43 | 0.080 |
Why?
|
Diagnostic Errors | 3 | 2019 | 509 | 0.080 |
Why?
|
Antibody Specificity | 2 | 2011 | 334 | 0.080 |
Why?
|
Alleles | 4 | 2017 | 2437 | 0.080 |
Why?
|
DNA Probes | 3 | 2011 | 217 | 0.080 |
Why?
|
Adipose Tissue, Brown | 2 | 1985 | 112 | 0.080 |
Why?
|
Inhibitor of Differentiation Protein 2 | 1 | 2008 | 17 | 0.080 |
Why?
|
Sugar Alcohol Dehydrogenases | 1 | 2007 | 12 | 0.080 |
Why?
|
Granulocytes | 1 | 1988 | 224 | 0.080 |
Why?
|
Antineoplastic Agents, Phytogenic | 3 | 2002 | 852 | 0.080 |
Why?
|
Lipoma | 2 | 1990 | 89 | 0.080 |
Why?
|
Socioeconomic Factors | 2 | 2011 | 1225 | 0.080 |
Why?
|
Monocytes | 4 | 2021 | 788 | 0.080 |
Why?
|
Endometrial Neoplasms | 2 | 2012 | 1341 | 0.080 |
Why?
|
Tyrosine | 3 | 2004 | 498 | 0.080 |
Why?
|
Ploidies | 4 | 2001 | 248 | 0.080 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2009 | 219 | 0.080 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2009 | 299 | 0.080 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2007 | 41 | 0.080 |
Why?
|
Antigens, Nuclear | 2 | 1998 | 119 | 0.080 |
Why?
|
RNA | 2 | 2023 | 1013 | 0.080 |
Why?
|
NFATC Transcription Factors | 2 | 2018 | 96 | 0.080 |
Why?
|
Aftercare | 2 | 2020 | 259 | 0.080 |
Why?
|
Interleukin-5 | 3 | 2001 | 73 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2007 | 48 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinase 9 | 1 | 2007 | 33 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2018 | 3821 | 0.070 |
Why?
|
Nucleic Acid Hybridization | 4 | 2008 | 542 | 0.070 |
Why?
|
Electrophoresis, Agar Gel | 5 | 1989 | 82 | 0.070 |
Why?
|
Papilloma | 2 | 1999 | 74 | 0.070 |
Why?
|
Fluorescent Dyes | 2 | 2013 | 459 | 0.070 |
Why?
|
Infectious Mononucleosis | 1 | 2007 | 33 | 0.070 |
Why?
|
Receptor, ErbB-2 | 1 | 2017 | 2518 | 0.070 |
Why?
|
Butadienes | 1 | 2006 | 35 | 0.070 |
Why?
|
Interleukin-1beta | 2 | 2020 | 300 | 0.070 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 3 | 2019 | 217 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2014 | 997 | 0.070 |
Why?
|
Mitotic Index | 3 | 2001 | 162 | 0.070 |
Why?
|
Cell Culture Techniques | 2 | 2000 | 598 | 0.070 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1989 | 223 | 0.070 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2006 | 54 | 0.070 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 4 | 2014 | 167 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2018 | 2594 | 0.070 |
Why?
|
History, 21st Century | 2 | 2019 | 441 | 0.070 |
Why?
|
Carcinoma, Papillary | 3 | 1999 | 584 | 0.070 |
Why?
|
Cloning, Molecular | 2 | 2005 | 1213 | 0.070 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2006 | 88 | 0.070 |
Why?
|
Abdomen | 2 | 2005 | 332 | 0.070 |
Why?
|
Autografts | 2 | 2018 | 165 | 0.070 |
Why?
|
Rhabdomyosarcoma | 1 | 2009 | 341 | 0.070 |
Why?
|
RNA, Small Interfering | 5 | 2012 | 2216 | 0.070 |
Why?
|
Rifabutin | 1 | 2006 | 25 | 0.070 |
Why?
|
Alternative Splicing | 2 | 2011 | 584 | 0.070 |
Why?
|
Medical Records | 2 | 2006 | 415 | 0.070 |
Why?
|
Anemia, Aplastic | 1 | 2007 | 214 | 0.070 |
Why?
|
Cholesteatoma | 1 | 1985 | 6 | 0.070 |
Why?
|
Mastectomy | 1 | 2012 | 1534 | 0.070 |
Why?
|
Diabetes Insipidus | 1 | 2005 | 26 | 0.070 |
Why?
|
History, 20th Century | 2 | 2019 | 574 | 0.070 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2013 | 726 | 0.070 |
Why?
|
Basophils | 2 | 2004 | 38 | 0.070 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2009 | 1833 | 0.070 |
Why?
|
Sarcoma, Ewing | 1 | 2009 | 406 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2015 | 4053 | 0.070 |
Why?
|
Laser Capture Microdissection | 2 | 2015 | 43 | 0.070 |
Why?
|
Allografts | 2 | 2020 | 650 | 0.070 |
Why?
|
Transfection | 4 | 2016 | 2944 | 0.070 |
Why?
|
Amino Acid Sequence | 4 | 2014 | 4233 | 0.070 |
Why?
|
Blood Protein Electrophoresis | 1 | 2005 | 9 | 0.070 |
Why?
|
Ultrafiltration | 1 | 1985 | 22 | 0.070 |
Why?
|
Fungemia | 1 | 2006 | 116 | 0.070 |
Why?
|
Zinc Finger Protein GLI1 | 3 | 2011 | 111 | 0.070 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 4 | 2003 | 568 | 0.070 |
Why?
|
Survival | 2 | 2019 | 177 | 0.070 |
Why?
|
Neoplasm Invasiveness | 5 | 2019 | 3981 | 0.070 |
Why?
|
Vimentin | 3 | 2002 | 253 | 0.070 |
Why?
|
Isoantibodies | 1 | 1986 | 115 | 0.070 |
Why?
|
Immunoglobulin Joining Region | 3 | 2002 | 14 | 0.070 |
Why?
|
RNA Interference | 3 | 2016 | 1408 | 0.070 |
Why?
|
Proteome | 1 | 2009 | 561 | 0.070 |
Why?
|
Interleukin Receptor Common gamma Subunit | 2 | 2015 | 47 | 0.070 |
Why?
|
Immunotherapy | 2 | 2016 | 3341 | 0.060 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2006 | 187 | 0.060 |
Why?
|
Heat-Shock Proteins | 1 | 2007 | 311 | 0.060 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2005 | 69 | 0.060 |
Why?
|
Dioxygenases | 2 | 2018 | 159 | 0.060 |
Why?
|
Suppressor of Cytokine Signaling 3 Protein | 1 | 2004 | 24 | 0.060 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2005 | 44 | 0.060 |
Why?
|
Exploratory Behavior | 2 | 2015 | 106 | 0.060 |
Why?
|
Clinical Trials as Topic | 4 | 2017 | 3719 | 0.060 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2004 | 60 | 0.060 |
Why?
|
Cerebellar Diseases | 1 | 1985 | 89 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2015 | 1226 | 0.060 |
Why?
|
Blood Cells | 2 | 2002 | 127 | 0.060 |
Why?
|
Hematologic Tests | 2 | 2007 | 82 | 0.060 |
Why?
|
fas Receptor | 1 | 2005 | 185 | 0.060 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 2 | 2001 | 74 | 0.060 |
Why?
|
Cell Differentiation | 6 | 2018 | 4078 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2012 | 4320 | 0.060 |
Why?
|
Tetracyclines | 1 | 1984 | 17 | 0.060 |
Why?
|
Pyridines | 1 | 2011 | 1244 | 0.060 |
Why?
|
Benzyl Compounds | 1 | 2004 | 10 | 0.060 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2011 | 588 | 0.060 |
Why?
|
Interphase | 2 | 2002 | 145 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2004 | 66 | 0.060 |
Why?
|
Thymus Gland | 3 | 2011 | 294 | 0.060 |
Why?
|
Restraint, Physical | 2 | 2015 | 50 | 0.060 |
Why?
|
Adrenal Glands | 3 | 1990 | 122 | 0.060 |
Why?
|
Hydrocarbons, Fluorinated | 1 | 2004 | 26 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2011 | 918 | 0.060 |
Why?
|
Models, Genetic | 2 | 2005 | 1113 | 0.060 |
Why?
|
Neurons | 1 | 2015 | 2287 | 0.060 |
Why?
|
Necrosis | 3 | 2009 | 580 | 0.060 |
Why?
|
Caspase Inhibitors | 1 | 2004 | 95 | 0.060 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2004 | 94 | 0.060 |
Why?
|
Gene Library | 2 | 2019 | 294 | 0.060 |
Why?
|
Lymphangitis | 1 | 2003 | 4 | 0.060 |
Why?
|
S100 Calcium Binding Protein G | 2 | 2000 | 50 | 0.060 |
Why?
|
Lactate Dehydrogenases | 1 | 2023 | 7 | 0.060 |
Why?
|
Candidiasis | 1 | 2006 | 262 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2023 | 28 | 0.060 |
Why?
|
Prevalence | 3 | 2018 | 3260 | 0.060 |
Why?
|
Logistic Models | 1 | 2011 | 3441 | 0.060 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2023 | 36 | 0.060 |
Why?
|
Positron Emission Tomography Computed Tomography | 2 | 2019 | 833 | 0.060 |
Why?
|
S Phase | 2 | 2009 | 281 | 0.060 |
Why?
|
Cause of Death | 2 | 2018 | 752 | 0.060 |
Why?
|
Leukemia, Radiation-Induced | 1 | 2003 | 24 | 0.060 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2021 | 179 | 0.060 |
Why?
|
Programmed Cell Death 1 Ligand 2 Protein | 2 | 2015 | 27 | 0.060 |
Why?
|
Bortezomib | 2 | 2018 | 543 | 0.060 |
Why?
|
COP9 Signalosome Complex | 1 | 2003 | 72 | 0.060 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2006 | 297 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 1489 | 0.060 |
Why?
|
Cell Adhesion Molecules | 2 | 2003 | 577 | 0.060 |
Why?
|
Transglutaminases | 1 | 2003 | 99 | 0.060 |
Why?
|
Growth Inhibitors | 2 | 2000 | 149 | 0.060 |
Why?
|
Pleural Effusion, Malignant | 1 | 2005 | 156 | 0.060 |
Why?
|
Models, Molecular | 2 | 2021 | 1732 | 0.060 |
Why?
|
Graft Survival | 2 | 2018 | 1062 | 0.060 |
Why?
|
Leukemia, Monocytic, Acute | 2 | 1999 | 31 | 0.050 |
Why?
|
Withholding Treatment | 1 | 2024 | 161 | 0.050 |
Why?
|
Trimetrexate | 1 | 2002 | 12 | 0.050 |
Why?
|
Cerebrospinal Fluid | 1 | 2003 | 120 | 0.050 |
Why?
|
In Vitro Techniques | 3 | 2013 | 1618 | 0.050 |
Why?
|
Immune Evasion | 1 | 2023 | 73 | 0.050 |
Why?
|
STAT1 Transcription Factor | 2 | 2014 | 156 | 0.050 |
Why?
|
Cyclin D | 3 | 2006 | 37 | 0.050 |
Why?
|
CD4 Antigens | 1 | 2003 | 170 | 0.050 |
Why?
|
Tretinoin | 1 | 2005 | 623 | 0.050 |
Why?
|
Minocycline | 1 | 1984 | 182 | 0.050 |
Why?
|
Multigene Family | 3 | 2017 | 425 | 0.050 |
Why?
|
Lymphokines | 2 | 2000 | 272 | 0.050 |
Why?
|
Skin Pigmentation | 1 | 2002 | 47 | 0.050 |
Why?
|
CD59 Antigens | 2 | 2014 | 11 | 0.050 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2002 | 129 | 0.050 |
Why?
|
Promyelocytic Leukemia Protein | 2 | 2013 | 55 | 0.050 |
Why?
|
CD13 Antigens | 1 | 2002 | 36 | 0.050 |
Why?
|
Transplantation Chimera | 2 | 2015 | 155 | 0.050 |
Why?
|
Prostatic Neoplasms | 3 | 2014 | 5767 | 0.050 |
Why?
|
Nitriles | 1 | 2006 | 906 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2010 | 2403 | 0.050 |
Why?
|
Digestive System | 1 | 2002 | 114 | 0.050 |
Why?
|
Hepatitis | 1 | 2002 | 93 | 0.050 |
Why?
|
Blood Donors | 1 | 2002 | 164 | 0.050 |
Why?
|
Mutation Rate | 2 | 2012 | 223 | 0.050 |
Why?
|
Anemia | 2 | 2021 | 689 | 0.050 |
Why?
|
Chemokines, CC | 1 | 2001 | 36 | 0.050 |
Why?
|
Viral Proteins | 1 | 2004 | 435 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2000 | 5437 | 0.050 |
Why?
|
Appendiceal Neoplasms | 1 | 2004 | 234 | 0.050 |
Why?
|
Mouth Neoplasms | 1 | 2007 | 713 | 0.050 |
Why?
|
Genes, abl | 2 | 2012 | 110 | 0.050 |
Why?
|
Deltaproteobacteria | 1 | 2021 | 1 | 0.050 |
Why?
|
Oligopeptides | 1 | 2004 | 429 | 0.050 |
Why?
|
Ethmoid Sinus | 1 | 2001 | 27 | 0.050 |
Why?
|
Homeodomain Proteins | 1 | 2007 | 1143 | 0.050 |
Why?
|
Prospective Studies | 6 | 2018 | 12873 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2001 | 121 | 0.050 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2001 | 116 | 0.050 |
Why?
|
Synaptophysin | 2 | 1998 | 79 | 0.050 |
Why?
|
Peptide Hydrolases | 1 | 2003 | 256 | 0.050 |
Why?
|
Cancer Vaccines | 1 | 2007 | 697 | 0.050 |
Why?
|
Microtubule-Associated Proteins | 1 | 2004 | 534 | 0.050 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2021 | 27 | 0.050 |
Why?
|
CD40 Antigens | 1 | 2001 | 104 | 0.050 |
Why?
|
Pain | 2 | 2015 | 1658 | 0.050 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 2001 | 50 | 0.050 |
Why?
|
Obesity | 1 | 2013 | 2884 | 0.050 |
Why?
|
Epididymis | 1 | 2001 | 68 | 0.050 |
Why?
|
Erythroblasts | 2 | 2010 | 24 | 0.050 |
Why?
|
Zinc Finger Protein Gli3 | 2 | 2011 | 12 | 0.050 |
Why?
|
Receptors, Chemokine | 1 | 2001 | 114 | 0.050 |
Why?
|
Poly-ADP-Ribose Binding Proteins | 1 | 2021 | 109 | 0.050 |
Why?
|
Immunoglobulin Isotypes | 1 | 2020 | 36 | 0.050 |
Why?
|
Caspase 9 | 3 | 2006 | 189 | 0.050 |
Why?
|
Zinc Finger Protein Gli2 | 2 | 2011 | 30 | 0.050 |
Why?
|
Phosphopyruvate Hydratase | 2 | 1998 | 87 | 0.050 |
Why?
|
Metaplasia | 2 | 2000 | 383 | 0.050 |
Why?
|
Lasers | 3 | 2007 | 198 | 0.050 |
Why?
|
Facial Pain | 1 | 2020 | 20 | 0.050 |
Why?
|
Carbamazepine | 1 | 2020 | 49 | 0.050 |
Why?
|
Nerve Growth Factor | 1 | 2020 | 45 | 0.050 |
Why?
|
Videoconferencing | 1 | 2020 | 56 | 0.050 |
Why?
|
Daunorubicin | 2 | 2014 | 301 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 2 | 2018 | 665 | 0.050 |
Why?
|
Ileum | 3 | 2012 | 165 | 0.050 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2000 | 46 | 0.050 |
Why?
|
Interleukin-1alpha | 1 | 2020 | 56 | 0.050 |
Why?
|
Keratin-7 | 1 | 2000 | 52 | 0.050 |
Why?
|
Animals, Newborn | 2 | 2014 | 1338 | 0.050 |
Why?
|
Cell Line | 3 | 2019 | 5114 | 0.050 |
Why?
|
Chromosome Breakpoints | 1 | 2020 | 104 | 0.050 |
Why?
|
Leiomyoma | 1 | 2001 | 145 | 0.050 |
Why?
|
DNA, Complementary | 1 | 2001 | 869 | 0.050 |
Why?
|
Pseudopodia | 1 | 1999 | 30 | 0.050 |
Why?
|
Meninges | 1 | 2000 | 47 | 0.050 |
Why?
|
Exodeoxyribonuclease V | 1 | 1999 | 28 | 0.050 |
Why?
|
Infusions, Intravenous | 4 | 2005 | 1382 | 0.040 |
Why?
|
Kidney | 2 | 1995 | 2146 | 0.040 |
Why?
|
Janus Kinase 1 | 2 | 2014 | 121 | 0.040 |
Why?
|
Body Weight | 2 | 2014 | 1293 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2014 | 1487 | 0.040 |
Why?
|
Camptothecin | 1 | 2002 | 517 | 0.040 |
Why?
|
Tissue Fixation | 2 | 2017 | 136 | 0.040 |
Why?
|
Quinazolines | 1 | 2004 | 923 | 0.040 |
Why?
|
Retinoblastoma-Binding Protein 1 | 4 | 2001 | 54 | 0.040 |
Why?
|
Cluster Analysis | 2 | 2014 | 1053 | 0.040 |
Why?
|
Transcription Factor DP1 | 4 | 2001 | 57 | 0.040 |
Why?
|
Culture Media, Conditioned | 1 | 2000 | 260 | 0.040 |
Why?
|
Analgesia | 1 | 2020 | 94 | 0.040 |
Why?
|
Polymorphism, Single-Stranded Conformational | 2 | 1996 | 176 | 0.040 |
Why?
|
Receptors, Antigen | 1 | 1999 | 76 | 0.040 |
Why?
|
Specialization | 1 | 2020 | 130 | 0.040 |
Why?
|
Interleukin-3 | 2 | 1999 | 96 | 0.040 |
Why?
|
Carbazoles | 1 | 2019 | 87 | 0.040 |
Why?
|
Computer Systems | 1 | 1999 | 106 | 0.040 |
Why?
|
Cell Death | 2 | 2014 | 671 | 0.040 |
Why?
|
E2F Transcription Factors | 4 | 2001 | 132 | 0.040 |
Why?
|
Salivary Glands | 1 | 2019 | 130 | 0.040 |
Why?
|
Pleural Effusion | 1 | 2001 | 201 | 0.040 |
Why?
|
HL-60 Cells | 2 | 2014 | 302 | 0.040 |
Why?
|
Polyploidy | 1 | 1999 | 73 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2003 | 2314 | 0.040 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 1999 | 36 | 0.040 |
Why?
|
Amino Acid Substitution | 2 | 2016 | 644 | 0.040 |
Why?
|
Vaginal Neoplasms | 1 | 2000 | 152 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2004 | 1555 | 0.040 |
Why?
|
Chromosomes | 1 | 1999 | 244 | 0.040 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2020 | 126 | 0.040 |
Why?
|
Duodenal Neoplasms | 1 | 1999 | 138 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2005 | 755 | 0.040 |
Why?
|
Patient Outcome Assessment | 1 | 2020 | 245 | 0.040 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2017 | 854 | 0.040 |
Why?
|
Acetylation | 2 | 2011 | 508 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2020 | 298 | 0.040 |
Why?
|
Lymphangioma | 1 | 1998 | 36 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2018 | 2292 | 0.040 |
Why?
|
Ultrasonography | 1 | 2005 | 1863 | 0.040 |
Why?
|
Neurosurgical Procedures | 1 | 2023 | 609 | 0.040 |
Why?
|
Carcinosarcoma | 1 | 2000 | 146 | 0.040 |
Why?
|
Ilium | 1 | 2018 | 54 | 0.040 |
Why?
|
Eosinophils | 3 | 2001 | 162 | 0.040 |
Why?
|
Flumazenil | 1 | 2017 | 8 | 0.040 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 362 | 0.040 |
Why?
|
Fibroblasts | 2 | 2003 | 1682 | 0.040 |
Why?
|
Adenosine A1 Receptor Antagonists | 1 | 2017 | 5 | 0.040 |
Why?
|
Automation, Laboratory | 1 | 2018 | 27 | 0.040 |
Why?
|
Dizocilpine Maleate | 1 | 2017 | 21 | 0.040 |
Why?
|
Histiocytosis, Non-Langerhans-Cell | 3 | 1993 | 25 | 0.040 |
Why?
|
Actuarial Analysis | 3 | 2001 | 159 | 0.040 |
Why?
|
GABA Modulators | 1 | 2017 | 15 | 0.040 |
Why?
|
Xanthines | 1 | 2017 | 29 | 0.040 |
Why?
|
HTLV-I Infections | 1 | 1997 | 16 | 0.040 |
Why?
|
Oncogene Protein v-akt | 1 | 2018 | 101 | 0.040 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2002 | 1299 | 0.040 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 1999 | 266 | 0.040 |
Why?
|
Immunoassay | 2 | 2010 | 216 | 0.040 |
Why?
|
Paraffin Embedding | 4 | 2002 | 226 | 0.040 |
Why?
|
Carmustine | 1 | 2018 | 214 | 0.040 |
Why?
|
Histocytochemistry | 2 | 1992 | 185 | 0.040 |
Why?
|
Naloxone | 1 | 2017 | 82 | 0.040 |
Why?
|
Hyperplasia | 3 | 2003 | 557 | 0.040 |
Why?
|
Physical Stimulation | 1 | 2017 | 112 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1999 | 408 | 0.040 |
Why?
|
Liver Cirrhosis, Biliary | 1 | 1998 | 78 | 0.040 |
Why?
|
Genotyping Techniques | 1 | 2018 | 166 | 0.040 |
Why?
|
Reference Values | 3 | 1998 | 1099 | 0.040 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 1998 | 178 | 0.040 |
Why?
|
Blood Cell Count | 1 | 1998 | 225 | 0.040 |
Why?
|
Myocardial Infarction | 4 | 1989 | 1374 | 0.040 |
Why?
|
Datasets as Topic | 1 | 2018 | 181 | 0.040 |
Why?
|
Protein Biosynthesis | 2 | 2012 | 889 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 1999 | 575 | 0.040 |
Why?
|
Megakaryocytes | 1 | 1998 | 104 | 0.040 |
Why?
|
Chromothripsis | 1 | 2017 | 13 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 1985 | 960 | 0.040 |
Why?
|
Molecular Sequence Annotation | 1 | 2018 | 201 | 0.040 |
Why?
|
Cell Size | 2 | 2011 | 136 | 0.040 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 1997 | 98 | 0.040 |
Why?
|
Oncogene Proteins, Viral | 1 | 1997 | 133 | 0.040 |
Why?
|
Aminopterin | 1 | 2016 | 30 | 0.040 |
Why?
|
Carcinoma, Endometrioid | 1 | 2000 | 323 | 0.040 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2017 | 61 | 0.040 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2017 | 151 | 0.040 |
Why?
|
Arabinonucleosides | 1 | 2019 | 437 | 0.040 |
Why?
|
Positive Regulatory Domain I-Binding Factor 1 | 1 | 2016 | 17 | 0.040 |
Why?
|
Dermis | 1 | 2017 | 65 | 0.040 |
Why?
|
Subcutaneous Tissue | 1 | 2017 | 62 | 0.040 |
Why?
|
Molecular Probes | 1 | 2017 | 72 | 0.040 |
Why?
|
Cross Reactions | 2 | 2011 | 266 | 0.040 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2003 | 716 | 0.040 |
Why?
|
Janus Kinases | 1 | 2018 | 174 | 0.040 |
Why?
|
Sex Distribution | 2 | 1995 | 495 | 0.040 |
Why?
|
Calcium | 1 | 2023 | 1537 | 0.040 |
Why?
|
Tetraspanins | 1 | 2016 | 42 | 0.040 |
Why?
|
CD55 Antigens | 2 | 2008 | 17 | 0.040 |
Why?
|
Touch | 1 | 2016 | 71 | 0.040 |
Why?
|
Epigenomics | 1 | 2018 | 266 | 0.040 |
Why?
|
Alemtuzumab | 1 | 2017 | 198 | 0.040 |
Why?
|
Physician's Role | 1 | 2019 | 238 | 0.040 |
Why?
|
Pilot Projects | 1 | 2003 | 2803 | 0.040 |
Why?
|
HIV-1 | 2 | 2017 | 653 | 0.040 |
Why?
|
Ifosfamide | 1 | 2017 | 344 | 0.040 |
Why?
|
Glycosylation | 1 | 2016 | 213 | 0.040 |
Why?
|
Depsipeptides | 1 | 2016 | 78 | 0.040 |
Why?
|
Age Distribution | 2 | 1995 | 698 | 0.040 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2017 | 146 | 0.040 |
Why?
|
Artifacts | 1 | 2019 | 532 | 0.040 |
Why?
|
Pregnancy | 2 | 2023 | 7573 | 0.040 |
Why?
|
Tennessee | 1 | 2016 | 36 | 0.030 |
Why?
|
Bone Marrow Transplantation | 3 | 2010 | 1581 | 0.030 |
Why?
|
Philippines | 1 | 1996 | 39 | 0.030 |
Why?
|
Pentostatin | 1 | 2016 | 119 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2002 | 2315 | 0.030 |
Why?
|
Chromones | 2 | 2006 | 120 | 0.030 |
Why?
|
Densitometry | 2 | 1986 | 45 | 0.030 |
Why?
|
Biopsy, Large-Core Needle | 1 | 2017 | 134 | 0.030 |
Why?
|
Clinical Decision-Making | 1 | 2019 | 524 | 0.030 |
Why?
|
Birefringence | 1 | 1995 | 7 | 0.030 |
Why?
|
Quality Control | 1 | 2017 | 457 | 0.030 |
Why?
|
Epistaxis | 1 | 2015 | 30 | 0.030 |
Why?
|
B-Lymphocyte Subsets | 2 | 2013 | 45 | 0.030 |
Why?
|
Liposomes | 2 | 2013 | 684 | 0.030 |
Why?
|
Indoles | 2 | 2012 | 1009 | 0.030 |
Why?
|
Photopheresis | 1 | 2016 | 79 | 0.030 |
Why?
|
Myosin Heavy Chains | 2 | 2006 | 128 | 0.030 |
Why?
|
Drug Resistance | 1 | 2017 | 587 | 0.030 |
Why?
|
Reticulin | 1 | 2015 | 22 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2015 | 130 | 0.030 |
Why?
|
Rats, Inbred WKY | 1 | 2015 | 110 | 0.030 |
Why?
|
Observer Variation | 1 | 1997 | 671 | 0.030 |
Why?
|
Cystadenocarcinoma, Mucinous | 1 | 1995 | 21 | 0.030 |
Why?
|
Methylprednisolone | 1 | 2016 | 193 | 0.030 |
Why?
|
Rats, Inbred SHR | 1 | 2015 | 113 | 0.030 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2017 | 242 | 0.030 |
Why?
|
Blotting, Northern | 3 | 2007 | 682 | 0.030 |
Why?
|
HLA-DR Antigens | 2 | 2011 | 173 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 2265 | 0.030 |
Why?
|
Giant Cell Tumors | 1 | 1995 | 33 | 0.030 |
Why?
|
Neutropenia | 2 | 2015 | 968 | 0.030 |
Why?
|
Clinical Competence | 1 | 2023 | 1270 | 0.030 |
Why?
|
Metaphase | 1 | 2015 | 107 | 0.030 |
Why?
|
Telomere | 2 | 2009 | 505 | 0.030 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2015 | 32 | 0.030 |
Why?
|
Genes, erbB-2 | 1 | 2016 | 229 | 0.030 |
Why?
|
Sampling Studies | 1 | 2015 | 170 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 289 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2013 | 5637 | 0.030 |
Why?
|
Immunoglobulin J-Chains | 1 | 1994 | 8 | 0.030 |
Why?
|
Temperature | 1 | 2016 | 506 | 0.030 |
Why?
|
Submandibular Gland Neoplasms | 1 | 2015 | 37 | 0.030 |
Why?
|
Endocrine Gland Neoplasms | 1 | 1995 | 42 | 0.030 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1997 | 362 | 0.030 |
Why?
|
Retinoic Acid Receptor alpha | 1 | 2015 | 95 | 0.030 |
Why?
|
Phycoerythrin | 1 | 2014 | 4 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2019 | 785 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 1399 | 0.030 |
Why?
|
Tetraspanin 30 | 1 | 2014 | 14 | 0.030 |
Why?
|
Brain Stem | 1 | 2015 | 175 | 0.030 |
Why?
|
Mesothelioma | 1 | 2000 | 544 | 0.030 |
Why?
|
Soft Tissue Neoplasms | 2 | 2015 | 882 | 0.030 |
Why?
|
Tacrolimus | 1 | 2016 | 335 | 0.030 |
Why?
|
Receptors, Complement 3b | 1 | 2014 | 20 | 0.030 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2014 | 52 | 0.030 |
Why?
|
Ileal Diseases | 1 | 1994 | 27 | 0.030 |
Why?
|
Administration, Oral | 2 | 2011 | 1544 | 0.030 |
Why?
|
Neovascularization, Pathologic | 2 | 2002 | 1547 | 0.030 |
Why?
|
Pimozide | 1 | 2014 | 9 | 0.030 |
Why?
|
Reflex | 1 | 2014 | 68 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2015 | 5710 | 0.030 |
Why?
|
Lymphocele | 1 | 2014 | 8 | 0.030 |
Why?
|
Glomerulonephritis | 1 | 1995 | 109 | 0.030 |
Why?
|
Semiconductors | 1 | 2014 | 22 | 0.030 |
Why?
|
Immunocompetence | 2 | 2011 | 75 | 0.030 |
Why?
|
Ovariectomy | 1 | 2015 | 330 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2015 | 445 | 0.030 |
Why?
|
Protein Transport | 1 | 2016 | 734 | 0.030 |
Why?
|
Evoked Potentials, Motor | 1 | 2014 | 58 | 0.030 |
Why?
|
Lung Diseases | 2 | 1992 | 717 | 0.030 |
Why?
|
Developed Countries | 1 | 2014 | 42 | 0.030 |
Why?
|
Interleukin-4 | 2 | 2006 | 284 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 2 | 2011 | 803 | 0.030 |
Why?
|
Dopamine | 1 | 2015 | 312 | 0.030 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 1995 | 110 | 0.030 |
Why?
|
E2F1 Transcription Factor | 3 | 2001 | 206 | 0.030 |
Why?
|
Forecasting | 1 | 2017 | 694 | 0.030 |
Why?
|
Rhodamines | 1 | 2013 | 49 | 0.030 |
Why?
|
Palliative Care | 1 | 2005 | 2037 | 0.030 |
Why?
|
Endoglin | 1 | 2013 | 43 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2014 | 162 | 0.030 |
Why?
|
Global Health | 1 | 2019 | 657 | 0.030 |
Why?
|
Reaction Time | 1 | 2014 | 234 | 0.030 |
Why?
|
Intermediate Filament Proteins | 1 | 1993 | 81 | 0.030 |
Why?
|
Corticosterone | 1 | 2013 | 119 | 0.030 |
Why?
|
Random Allocation | 1 | 2015 | 703 | 0.030 |
Why?
|
Electric Stimulation | 1 | 2015 | 426 | 0.030 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 208 | 0.030 |
Why?
|
Tissue Distribution | 2 | 2008 | 875 | 0.030 |
Why?
|
Mice, Inbred CBA | 1 | 2013 | 78 | 0.030 |
Why?
|
Odds Ratio | 2 | 2011 | 2316 | 0.030 |
Why?
|
Thymus Hormones | 1 | 1993 | 2 | 0.030 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2006 | 2341 | 0.030 |
Why?
|
Fucosyltransferases | 1 | 2013 | 76 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2015 | 327 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2015 | 1082 | 0.030 |
Why?
|
Adipose Tissue, White | 1 | 2013 | 99 | 0.030 |
Why?
|
Prednisolone | 1 | 2013 | 123 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 1 | 2023 | 1763 | 0.030 |
Why?
|
Nevus, Pigmented | 1 | 1993 | 104 | 0.030 |
Why?
|
Multimodal Imaging | 1 | 2017 | 550 | 0.030 |
Why?
|
Cerebral Hemorrhage | 1 | 2014 | 183 | 0.030 |
Why?
|
Neural Pathways | 1 | 2015 | 298 | 0.030 |
Why?
|
5' Untranslated Regions | 1 | 2013 | 93 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 461 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2015 | 702 | 0.030 |
Why?
|
Preoperative Period | 1 | 2014 | 344 | 0.030 |
Why?
|
Common Variable Immunodeficiency | 1 | 1992 | 30 | 0.030 |
Why?
|
Neurilemmoma | 1 | 1993 | 127 | 0.030 |
Why?
|
Restriction Mapping | 3 | 2005 | 264 | 0.030 |
Why?
|
Adiponectin | 1 | 2013 | 163 | 0.030 |
Why?
|
Pandemics | 1 | 2022 | 1559 | 0.030 |
Why?
|
Antibodies | 2 | 2009 | 838 | 0.030 |
Why?
|
Genes, T-Cell Receptor delta | 1 | 2012 | 13 | 0.030 |
Why?
|
Decision Trees | 1 | 1993 | 178 | 0.030 |
Why?
|
Opportunistic Infections | 1 | 2014 | 223 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2016 | 745 | 0.030 |
Why?
|
Histones | 2 | 2011 | 1466 | 0.030 |
Why?
|
Activin Receptors, Type II | 1 | 2012 | 38 | 0.030 |
Why?
|
Benzene | 1 | 2012 | 45 | 0.030 |
Why?
|
Antigens, CD1 | 1 | 2012 | 49 | 0.030 |
Why?
|
Colon, Ascending | 1 | 2012 | 12 | 0.030 |
Why?
|
Validation Studies as Topic | 1 | 2012 | 43 | 0.030 |
Why?
|
Xenobiotics | 1 | 2012 | 44 | 0.030 |
Why?
|
Mutagenesis, Insertional | 1 | 2013 | 218 | 0.030 |
Why?
|
DNA Restriction Enzymes | 1 | 1992 | 117 | 0.030 |
Why?
|
Alcoholism | 1 | 2015 | 285 | 0.030 |
Why?
|
Signaling Lymphocytic Activation Molecule Family Member 1 | 1 | 2011 | 10 | 0.030 |
Why?
|
Color | 1 | 2012 | 66 | 0.030 |
Why?
|
Fever | 1 | 2015 | 497 | 0.030 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2012 | 63 | 0.030 |
Why?
|
CD79 Antigens | 2 | 2003 | 7 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 2012 | 61 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2012 | 55 | 0.030 |
Why?
|
Digestive System Diseases | 1 | 1992 | 35 | 0.030 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 430 | 0.030 |
Why?
|
ErbB Receptors | 1 | 2020 | 2295 | 0.030 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 2 | 1989 | 72 | 0.030 |
Why?
|
Nucleic Acid Denaturation | 1 | 2011 | 34 | 0.030 |
Why?
|
Mucous Membrane | 2 | 1993 | 271 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 502 | 0.030 |
Why?
|
K562 Cells | 1 | 2012 | 338 | 0.030 |
Why?
|
Adiposity | 1 | 2013 | 237 | 0.030 |
Why?
|
STAT6 Transcription Factor | 1 | 2012 | 67 | 0.030 |
Why?
|
Frozen Sections | 2 | 1989 | 105 | 0.030 |
Why?
|
Postoperative Period | 1 | 2014 | 665 | 0.030 |
Why?
|
PAX8 Transcription Factor | 1 | 2011 | 55 | 0.030 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 615 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2019 | 929 | 0.030 |
Why?
|
Digestive System Neoplasms | 1 | 1992 | 82 | 0.030 |
Why?
|
International Cooperation | 1 | 2013 | 323 | 0.030 |
Why?
|
Radioimmunotherapy | 1 | 2012 | 119 | 0.030 |
Why?
|
CD28 Antigens | 1 | 2012 | 202 | 0.020 |
Why?
|
Calcitonin | 1 | 1992 | 186 | 0.020 |
Why?
|
Bromodeoxyuridine | 2 | 2001 | 139 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2015 | 410 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2013 | 330 | 0.020 |
Why?
|
Foreskin | 1 | 2011 | 8 | 0.020 |
Why?
|
Tonsillitis | 1 | 2011 | 16 | 0.020 |
Why?
|
Sleep | 1 | 2014 | 413 | 0.020 |
Why?
|
HIV Seropositivity | 1 | 2012 | 144 | 0.020 |
Why?
|
N-Myc Proto-Oncogene Protein | 1 | 2011 | 82 | 0.020 |
Why?
|
Nitrophenols | 1 | 2011 | 92 | 0.020 |
Why?
|
Lipopolysaccharide Receptors | 1 | 1991 | 86 | 0.020 |
Why?
|
Busulfan | 1 | 2015 | 764 | 0.020 |
Why?
|
Ribosomal Protein S6 | 1 | 2010 | 46 | 0.020 |
Why?
|
Facial Neoplasms | 1 | 1991 | 84 | 0.020 |
Why?
|
Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2010 | 18 | 0.020 |
Why?
|
Linear Models | 1 | 2014 | 1085 | 0.020 |
Why?
|
North America | 1 | 2011 | 314 | 0.020 |
Why?
|
Protein Conformation | 1 | 2014 | 1258 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2014 | 324 | 0.020 |
Why?
|
Clinical Enzyme Tests | 1 | 2010 | 25 | 0.020 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2010 | 22 | 0.020 |
Why?
|
Adrenal Cortex | 1 | 1990 | 35 | 0.020 |
Why?
|
Weight Loss | 1 | 2015 | 627 | 0.020 |
Why?
|
B-Cell Activating Factor | 1 | 2010 | 25 | 0.020 |
Why?
|
TNF Receptor-Associated Factor 2 | 1 | 2010 | 39 | 0.020 |
Why?
|
NF-KappaB Inhibitor alpha | 1 | 2010 | 136 | 0.020 |
Why?
|
HIV | 1 | 2012 | 229 | 0.020 |
Why?
|
Cladribine | 1 | 2001 | 233 | 0.020 |
Why?
|
Matched-Pair Analysis | 1 | 2010 | 103 | 0.020 |
Why?
|
Anemia, Refractory, with Excess of Blasts | 1 | 2010 | 86 | 0.020 |
Why?
|
Medication Adherence | 1 | 2015 | 492 | 0.020 |
Why?
|
Chemokines | 1 | 2012 | 314 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 1258 | 0.020 |
Why?
|
Models, Animal | 1 | 2013 | 664 | 0.020 |
Why?
|
Esophagus | 2 | 1997 | 553 | 0.020 |
Why?
|
Weight Gain | 1 | 2013 | 464 | 0.020 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 2 | 1992 | 674 | 0.020 |
Why?
|
Cholesterol | 1 | 2013 | 658 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 1489 | 0.020 |
Why?
|
Immunoradiometric Assay | 1 | 1989 | 4 | 0.020 |
Why?
|
Gene Silencing | 1 | 2013 | 837 | 0.020 |
Why?
|
CD4-CD8 Ratio | 1 | 2010 | 58 | 0.020 |
Why?
|
Leukemia Inhibitory Factor | 2 | 2000 | 39 | 0.020 |
Why?
|
Tetraspanin 28 | 1 | 2009 | 13 | 0.020 |
Why?
|
I-kappa B Proteins | 1 | 2010 | 170 | 0.020 |
Why?
|
Software | 1 | 2017 | 1321 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2010 | 148 | 0.020 |
Why?
|
Biphenyl Compounds | 1 | 2011 | 194 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 2 | 2009 | 582 | 0.020 |
Why?
|
Belgium | 1 | 2009 | 47 | 0.020 |
Why?
|
DNA Damage | 1 | 2018 | 1954 | 0.020 |
Why?
|
beta 2-Microglobulin | 1 | 2010 | 184 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2010 | 218 | 0.020 |
Why?
|
Pancreatic Neoplasms | 2 | 1999 | 5061 | 0.020 |
Why?
|
Chemokine CXCL13 | 1 | 2009 | 21 | 0.020 |
Why?
|
Lymphocyte Subsets | 1 | 2010 | 137 | 0.020 |
Why?
|
Azacitidine | 1 | 2016 | 1149 | 0.020 |
Why?
|
Everolimus | 1 | 2012 | 415 | 0.020 |
Why?
|
Risk | 1 | 2014 | 1972 | 0.020 |
Why?
|
Elastic Tissue | 1 | 1989 | 34 | 0.020 |
Why?
|
Esophageal Fistula | 1 | 1989 | 27 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2011 | 566 | 0.020 |
Why?
|
Histological Techniques | 1 | 1989 | 65 | 0.020 |
Why?
|
Prostatectomy | 1 | 2014 | 962 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2006 | 4849 | 0.020 |
Why?
|
Boronic Acids | 1 | 2011 | 362 | 0.020 |
Why?
|
Societies, Medical | 2 | 2010 | 1335 | 0.020 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2009 | 116 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2009 | 201 | 0.020 |
Why?
|
Intubation, Gastrointestinal | 1 | 1989 | 79 | 0.020 |
Why?
|
Cold Temperature | 1 | 2009 | 121 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2013 | 673 | 0.020 |
Why?
|
Models, Statistical | 2 | 2005 | 1171 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2012 | 413 | 0.020 |
Why?
|
Histocompatibility Antigens | 1 | 1988 | 74 | 0.020 |
Why?
|
Receptor Cross-Talk | 1 | 2009 | 79 | 0.020 |
Why?
|
Ovary | 1 | 1993 | 668 | 0.020 |
Why?
|
Fistula | 1 | 1989 | 76 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2007 | 4143 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2013 | 778 | 0.020 |
Why?
|
Computer Simulation | 1 | 2014 | 1529 | 0.020 |
Why?
|
Lymphoid Progenitor Cells | 1 | 2008 | 9 | 0.020 |
Why?
|
Tryptases | 1 | 2008 | 48 | 0.020 |
Why?
|
Stem Cell Factor | 1 | 2008 | 87 | 0.020 |
Why?
|
China | 1 | 2010 | 606 | 0.020 |
Why?
|
Synovial Membrane | 1 | 1988 | 41 | 0.020 |
Why?
|
Exome | 1 | 2014 | 1239 | 0.020 |
Why?
|
Adenoma, Bile Duct | 1 | 1988 | 2 | 0.020 |
Why?
|
Aurora Kinases | 1 | 2008 | 189 | 0.020 |
Why?
|
Renal Veins | 1 | 1988 | 56 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2014 | 2588 | 0.020 |
Why?
|
Atrial Fibrillation | 1 | 2015 | 719 | 0.020 |
Why?
|
Granulocyte Precursor Cells | 1 | 2008 | 37 | 0.020 |
Why?
|
Graft vs Tumor Effect | 1 | 2008 | 139 | 0.020 |
Why?
|
Protein Stability | 1 | 2009 | 370 | 0.020 |
Why?
|
Interferon-gamma | 1 | 1992 | 1144 | 0.020 |
Why?
|
Testosterone | 1 | 1992 | 619 | 0.020 |
Why?
|
California | 1 | 1988 | 208 | 0.020 |
Why?
|
Telomere-Binding Proteins | 1 | 2008 | 85 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 1270 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 1323 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1989 | 330 | 0.020 |
Why?
|
Anthracenes | 1 | 2007 | 48 | 0.020 |
Why?
|
Cyclin A | 1 | 2007 | 47 | 0.020 |
Why?
|
HeLa Cells | 1 | 2011 | 1643 | 0.020 |
Why?
|
Osteoclasts | 1 | 1988 | 165 | 0.020 |
Why?
|
Pyrroles | 1 | 2011 | 576 | 0.020 |
Why?
|
Electrophoresis | 1 | 1987 | 60 | 0.020 |
Why?
|
Sarcoma, Synovial | 1 | 1988 | 119 | 0.020 |
Why?
|
Resting Phase, Cell Cycle | 1 | 2006 | 35 | 0.020 |
Why?
|
Injections, Intradermal | 1 | 2007 | 58 | 0.020 |
Why?
|
Cellular Senescence | 1 | 2009 | 382 | 0.020 |
Why?
|
VDJ Exons | 1 | 2006 | 7 | 0.020 |
Why?
|
Protein Binding | 2 | 2004 | 3438 | 0.020 |
Why?
|
Syndecans | 1 | 2006 | 27 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2016 | 1371 | 0.020 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2012 | 598 | 0.020 |
Why?
|
Aortic Diseases | 1 | 1989 | 206 | 0.020 |
Why?
|
Angina Pectoris | 1 | 1987 | 80 | 0.020 |
Why?
|
Virus Latency | 1 | 1997 | 78 | 0.020 |
Why?
|
Epithelium | 1 | 1989 | 720 | 0.020 |
Why?
|
Syndecan-1 | 1 | 2006 | 52 | 0.020 |
Why?
|
p21-Activated Kinases | 1 | 2007 | 122 | 0.020 |
Why?
|
Mastectomy, Segmental | 1 | 1992 | 1026 | 0.020 |
Why?
|
Cytochromes c | 1 | 2006 | 118 | 0.020 |
Why?
|
Antigens, Viral | 2 | 1999 | 471 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 2992 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 1988 | 309 | 0.020 |
Why?
|
Mouth Mucosa | 1 | 2007 | 216 | 0.020 |
Why?
|
Phagocytosis | 1 | 1997 | 260 | 0.020 |
Why?
|
Tumor Necrosis Factors | 1 | 2006 | 34 | 0.020 |
Why?
|
Fingers | 1 | 2007 | 120 | 0.020 |
Why?
|
Receptor Activator of Nuclear Factor-kappa B | 1 | 2006 | 46 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2007 | 246 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2009 | 650 | 0.020 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2005 | 38 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 259 | 0.020 |
Why?
|
CD52 Antigen | 1 | 2005 | 46 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2006 | 129 | 0.020 |
Why?
|
Immunosorbent Techniques | 1 | 1985 | 57 | 0.020 |
Why?
|
Annexin A5 | 1 | 2005 | 72 | 0.020 |
Why?
|
Fluorometry | 1 | 1985 | 34 | 0.020 |
Why?
|
Paranasal Sinus Diseases | 1 | 1985 | 26 | 0.020 |
Why?
|
Receptors, Interleukin-15 | 1 | 2005 | 20 | 0.020 |
Why?
|
Ear Diseases | 1 | 1985 | 21 | 0.020 |
Why?
|
Proteoglycans | 1 | 2006 | 259 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2006 | 198 | 0.020 |
Why?
|
Actins | 2 | 2002 | 608 | 0.020 |
Why?
|
Ear, Middle | 1 | 1985 | 48 | 0.020 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2017 | 3251 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2011 | 1353 | 0.020 |
Why?
|
CD40 Ligand | 1 | 2006 | 115 | 0.020 |
Why?
|
Spectrometry, Fluorescence | 1 | 1986 | 209 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2012 | 1533 | 0.020 |
Why?
|
Caspase 8 | 1 | 2005 | 145 | 0.020 |
Why?
|
Adipose Tissue | 1 | 1990 | 769 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2012 | 1648 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 280 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1993 | 2086 | 0.020 |
Why?
|
RANK Ligand | 1 | 2006 | 119 | 0.020 |
Why?
|
Pleural Cavity | 1 | 2005 | 25 | 0.020 |
Why?
|
Scalp | 2 | 2000 | 156 | 0.020 |
Why?
|
Mitosis | 1 | 1987 | 615 | 0.020 |
Why?
|
Histone Deacetylases | 1 | 2007 | 365 | 0.020 |
Why?
|
Cyclophilins | 1 | 2004 | 32 | 0.020 |
Why?
|
beta 2-Glycoprotein I | 1 | 2004 | 16 | 0.020 |
Why?
|
Caspase 10 | 1 | 2004 | 21 | 0.020 |
Why?
|
Cytoplasmic Granules | 1 | 1985 | 89 | 0.020 |
Why?
|
Enzyme Precursors | 1 | 2004 | 66 | 0.020 |
Why?
|
ADP-ribosyl Cyclase | 1 | 2004 | 33 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2004 | 54 | 0.020 |
Why?
|
Bone Diseases | 1 | 1985 | 143 | 0.020 |
Why?
|
Norepinephrine | 1 | 1985 | 272 | 0.020 |
Why?
|
Haplorhini | 1 | 1984 | 130 | 0.020 |
Why?
|
Receptors, OX40 | 1 | 2004 | 50 | 0.020 |
Why?
|
Epinephrine | 1 | 1985 | 255 | 0.020 |
Why?
|
Acute-Phase Proteins | 1 | 2004 | 79 | 0.020 |
Why?
|
Receptors, Complement 3d | 1 | 2003 | 8 | 0.020 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2003 | 14 | 0.020 |
Why?
|
Interleukin-15 | 1 | 2005 | 185 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 1450 | 0.020 |
Why?
|
Erythrocyte Transfusion | 1 | 1986 | 212 | 0.010 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2004 | 191 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2004 | 184 | 0.010 |
Why?
|
Filtration | 1 | 1984 | 92 | 0.010 |
Why?
|
Skull | 1 | 1985 | 231 | 0.010 |
Why?
|
Rupture | 1 | 1983 | 61 | 0.010 |
Why?
|
RNA Precursors | 1 | 2004 | 137 | 0.010 |
Why?
|
Chemokines, CXC | 1 | 2003 | 117 | 0.010 |
Why?
|
Receptors, Interleukin-3 | 1 | 2003 | 26 | 0.010 |
Why?
|
Tyrphostins | 1 | 2003 | 107 | 0.010 |
Why?
|
Sialic Acid Binding Ig-like Lectin 2 | 1 | 2003 | 53 | 0.010 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2003 | 195 | 0.010 |
Why?
|
Archives | 1 | 2002 | 6 | 0.010 |
Why?
|
Lectins | 1 | 2003 | 151 | 0.010 |
Why?
|
Cyclophilin A | 1 | 2002 | 16 | 0.010 |
Why?
|
Bile Duct Neoplasms | 1 | 1988 | 493 | 0.010 |
Why?
|
Cell Transformation, Viral | 1 | 2003 | 138 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 482 | 0.010 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2004 | 324 | 0.010 |
Why?
|
Cell Aggregation | 1 | 2002 | 61 | 0.010 |
Why?
|
Genes, T-Cell Receptor gamma | 1 | 2002 | 5 | 0.010 |
Why?
|
Chromatin | 2 | 2002 | 942 | 0.010 |
Why?
|
Osteosarcoma | 1 | 2009 | 929 | 0.010 |
Why?
|
Blood Transfusion | 1 | 1986 | 583 | 0.010 |
Why?
|
Dogs | 1 | 1984 | 1155 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2003 | 289 | 0.010 |
Why?
|
12E7 Antigen | 1 | 2001 | 11 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 6942 | 0.010 |
Why?
|
Codon | 1 | 2002 | 241 | 0.010 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2003 | 163 | 0.010 |
Why?
|
Genetics, Population | 1 | 2003 | 242 | 0.010 |
Why?
|
Chemokine CCL11 | 1 | 2001 | 18 | 0.010 |
Why?
|
Mitoxantrone | 1 | 2002 | 216 | 0.010 |
Why?
|
RNA, Long Noncoding | 1 | 2007 | 598 | 0.010 |
Why?
|
Y Chromosome | 1 | 2001 | 77 | 0.010 |
Why?
|
Endoscopy, Digestive System | 1 | 2003 | 202 | 0.010 |
Why?
|
Receptors, CXCR3 | 1 | 2001 | 36 | 0.010 |
Why?
|
Sarcoma, Kaposi | 1 | 2003 | 187 | 0.010 |
Why?
|
Calbindin 1 | 1 | 2000 | 4 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2003 | 694 | 0.010 |
Why?
|
Calbindins | 1 | 2000 | 21 | 0.010 |
Why?
|
Calbindin 2 | 1 | 2000 | 40 | 0.010 |
Why?
|
Orchiectomy | 1 | 2001 | 214 | 0.010 |
Why?
|
Vulva | 1 | 2000 | 37 | 0.010 |
Why?
|
Thrombomodulin | 1 | 2000 | 30 | 0.010 |
Why?
|
JC Virus | 1 | 2000 | 43 | 0.010 |
Why?
|
Exonucleases | 1 | 2000 | 51 | 0.010 |
Why?
|
Ganglioneuroma | 1 | 2000 | 41 | 0.010 |
Why?
|
Thy-1 Antigens | 1 | 2000 | 51 | 0.010 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2000 | 103 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2001 | 359 | 0.010 |
Why?
|
Antifungal Agents | 1 | 2006 | 834 | 0.010 |
Why?
|
Melanocytes | 1 | 2001 | 219 | 0.010 |
Why?
|
Eosine Yellowish-(YS) | 1 | 1999 | 33 | 0.010 |
Why?
|
Mice, Nude | 1 | 2007 | 4307 | 0.010 |
Why?
|
Hematoxylin | 1 | 1999 | 34 | 0.010 |
Why?
|
Uterine Hemorrhage | 1 | 2000 | 59 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 2 | 1992 | 2027 | 0.010 |
Why?
|
Stomatitis | 1 | 2000 | 183 | 0.010 |
Why?
|
Prostate | 1 | 2005 | 1088 | 0.010 |
Why?
|
Chromogranins | 1 | 1999 | 84 | 0.010 |
Why?
|
Cyclin E | 1 | 2001 | 267 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2001 | 476 | 0.010 |
Why?
|
France | 1 | 1999 | 108 | 0.010 |
Why?
|
Maximum Tolerated Dose | 1 | 2002 | 1290 | 0.010 |
Why?
|
Genetics, Medical | 1 | 2000 | 143 | 0.010 |
Why?
|
Costa Rica | 1 | 1998 | 13 | 0.010 |
Why?
|
United Kingdom | 1 | 1999 | 257 | 0.010 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 1998 | 16 | 0.010 |
Why?
|
Nevus | 1 | 1999 | 107 | 0.010 |
Why?
|
Drug Carriers | 1 | 2000 | 327 | 0.010 |
Why?
|
Deltaretrovirus Antigens | 1 | 1997 | 1 | 0.010 |
Why?
|
Romania | 1 | 1997 | 12 | 0.010 |
Why?
|
Perforin | 1 | 1998 | 52 | 0.010 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 1997 | 71 | 0.010 |
Why?
|
Carcinoma, Small Cell | 1 | 2000 | 408 | 0.010 |
Why?
|
Automation | 1 | 1998 | 151 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2005 | 8223 | 0.010 |
Why?
|
Adenoviridae | 1 | 2003 | 1459 | 0.010 |
Why?
|
Carrier State | 1 | 1997 | 90 | 0.010 |
Why?
|
Communicable Diseases | 1 | 2000 | 193 | 0.010 |
Why?
|
Practice Patterns, Physicians' | 1 | 2006 | 1303 | 0.010 |
Why?
|
Hysterectomy | 1 | 2000 | 611 | 0.010 |
Why?
|
Palatine Tonsil | 1 | 1996 | 53 | 0.010 |
Why?
|
Oligonucleotides | 1 | 1997 | 227 | 0.010 |
Why?
|
Hepatitis C | 1 | 2001 | 524 | 0.010 |
Why?
|
Hypertension | 1 | 1985 | 1503 | 0.010 |
Why?
|
Sarcoma | 1 | 2006 | 1725 | 0.010 |
Why?
|
Neurosecretory Systems | 1 | 1995 | 66 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1995 | 130 | 0.010 |
Why?
|
HLA Antigens | 1 | 1998 | 546 | 0.010 |
Why?
|
Plasmapheresis | 1 | 1995 | 61 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 1985 | 1362 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 1998 | 749 | 0.010 |
Why?
|
Syncope | 1 | 1995 | 64 | 0.010 |
Why?
|
Patient Selection | 1 | 2002 | 2055 | 0.010 |
Why?
|
Factor VIII | 1 | 1994 | 75 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1993 | 48 | 0.010 |
Why?
|
Organ Specificity | 1 | 1995 | 699 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2001 | 1230 | 0.010 |
Why?
|
Interferon-alpha | 1 | 1997 | 889 | 0.010 |
Why?
|
Lung Diseases, Interstitial | 1 | 1995 | 199 | 0.010 |
Why?
|
Forehead | 1 | 1991 | 27 | 0.010 |
Why?
|
Medical Oncology | 1 | 2000 | 1423 | 0.010 |
Why?
|
Immunoblotting | 1 | 1992 | 886 | 0.010 |
Why?
|
Paraffin | 1 | 1989 | 13 | 0.010 |
Why?
|
Tissue Adhesions | 1 | 1989 | 60 | 0.010 |
Why?
|
Esophageal Diseases | 1 | 1989 | 69 | 0.010 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 1988 | 25 | 0.010 |
Why?
|
Receptors, Complement | 1 | 1988 | 48 | 0.010 |
Why?
|
Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 1987 | 34 | 0.000 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 1987 | 88 | 0.000 |
Why?
|
Immunologic Techniques | 1 | 1987 | 43 | 0.000 |
Why?
|
Antigens | 1 | 1988 | 292 | 0.000 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1989 | 340 | 0.000 |
Why?
|
Osteoblasts | 1 | 1988 | 370 | 0.000 |
Why?
|
Epitopes | 1 | 1988 | 685 | 0.000 |
Why?
|
Patient Discharge | 1 | 1989 | 661 | 0.000 |
Why?
|
Cell Membrane | 1 | 1987 | 850 | 0.000 |
Why?
|
Smoking | 1 | 1987 | 2440 | 0.000 |
Why?
|